US20020160400A1 - Radiative decay engineering - Google Patents
Radiative decay engineering Download PDFInfo
- Publication number
- US20020160400A1 US20020160400A1 US10/073,625 US7362502A US2002160400A1 US 20020160400 A1 US20020160400 A1 US 20020160400A1 US 7362502 A US7362502 A US 7362502A US 2002160400 A1 US2002160400 A1 US 2002160400A1
- Authority
- US
- United States
- Prior art keywords
- biomolecule
- metal particle
- fluorophore
- fluorescence
- emission
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002923 metal particle Substances 0.000 claims abstract description 120
- 239000000523 sample Substances 0.000 claims abstract description 99
- 238000000034 method Methods 0.000 claims abstract description 90
- 230000001965 increasing effect Effects 0.000 claims abstract description 79
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 72
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 52
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 52
- 239000000203 mixture Substances 0.000 claims abstract description 39
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 139
- 229910052709 silver Inorganic materials 0.000 claims description 138
- 239000004332 silver Substances 0.000 claims description 138
- 230000005855 radiation Effects 0.000 claims description 60
- 229910052751 metal Inorganic materials 0.000 claims description 58
- 239000002184 metal Substances 0.000 claims description 58
- 108090000623 proteins and genes Proteins 0.000 claims description 47
- 102000004169 proteins and genes Human genes 0.000 claims description 42
- 238000012546 transfer Methods 0.000 claims description 32
- 230000004044 response Effects 0.000 claims description 30
- 238000002493 microarray Methods 0.000 claims description 19
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 17
- 238000002372 labelling Methods 0.000 claims description 16
- 230000005670 electromagnetic radiation Effects 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 14
- 229910000510 noble metal Inorganic materials 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 230000002708 enhancing effect Effects 0.000 claims description 8
- 239000013528 metallic particle Substances 0.000 claims description 8
- 108091034117 Oligonucleotide Proteins 0.000 claims description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 229910052741 iridium Inorganic materials 0.000 claims description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- 229910052762 osmium Inorganic materials 0.000 claims description 3
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 229910052702 rhenium Inorganic materials 0.000 claims description 3
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 claims description 3
- 229910052703 rhodium Inorganic materials 0.000 claims description 3
- 239000010948 rhodium Substances 0.000 claims description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 3
- 229910052707 ruthenium Inorganic materials 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 claims description 3
- 239000002777 nucleoside Substances 0.000 claims description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
- 238000006862 quantum yield reaction Methods 0.000 abstract description 33
- 230000005284 excitation Effects 0.000 description 68
- 108020004414 DNA Proteins 0.000 description 64
- 239000000370 acceptor Substances 0.000 description 58
- 239000010453 quartz Substances 0.000 description 57
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 57
- 239000010408 film Substances 0.000 description 53
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 53
- 229940043267 rhodamine b Drugs 0.000 description 52
- 238000000295 emission spectrum Methods 0.000 description 41
- 235000018102 proteins Nutrition 0.000 description 41
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 36
- 229930187593 rose bengal Natural products 0.000 description 33
- 229940081623 rose bengal Drugs 0.000 description 33
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 33
- 230000000694 effects Effects 0.000 description 26
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 23
- 238000002165 resonance energy transfer Methods 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- 238000005259 measurement Methods 0.000 description 18
- 239000002245 particle Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 13
- 230000007423 decrease Effects 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 11
- 238000000862 absorption spectrum Methods 0.000 description 11
- 229940098773 bovine serum albumin Drugs 0.000 description 11
- 244000309466 calf Species 0.000 description 11
- 210000001541 thymus gland Anatomy 0.000 description 11
- FWEOQOXTVHGIFQ-UHFFFAOYSA-N 8-anilinonaphthalene-1-sulfonic acid Chemical compound C=12C(S(=O)(=O)O)=CC=CC2=CC=CC=1NC1=CC=CC=C1 FWEOQOXTVHGIFQ-UHFFFAOYSA-N 0.000 description 10
- 230000003247 decreasing effect Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 9
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 9
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical group Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 9
- 239000000084 colloidal system Substances 0.000 description 9
- -1 Fluorenyl fatty acid Chemical class 0.000 description 8
- 239000012491 analyte Substances 0.000 description 8
- 102000005936 beta-Galactosidase Human genes 0.000 description 8
- 108010005774 beta-Galactosidase Proteins 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 7
- 230000027455 binding Effects 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 6
- 238000003491 array Methods 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 6
- 239000002853 nucleic acid probe Substances 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 108091093037 Peptide nucleic acid Proteins 0.000 description 5
- 239000008364 bulk solution Substances 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 239000005092 [Ru (Bpy)3]2+ Substances 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 150000003212 purines Chemical class 0.000 description 4
- 150000003230 pyrimidines Chemical class 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- COIVODZMVVUETJ-UHFFFAOYSA-N sulforhodamine 101 Chemical group OS(=O)(=O)C1=CC(S([O-])(=O)=O)=CC=C1C1=C(C=C2C3=C4CCCN3CCC2)C4=[O+]C2=C1C=C1CCCN3CCCC2=C13 COIVODZMVVUETJ-UHFFFAOYSA-N 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 229920001222 biopolymer Polymers 0.000 description 3
- PFYXSUNOLOJMDX-UHFFFAOYSA-N bis(2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)ON1C(=O)CCC1=O PFYXSUNOLOJMDX-UHFFFAOYSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- BVQAWSJMUYMNQN-UHFFFAOYSA-N dipyridophenazine Chemical compound C1=CC=C2C3=NC4=CC=CC=C4N=C3C3=CC=CN=C3C2=N1 BVQAWSJMUYMNQN-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000007901 in situ hybridization Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- HMWAJFNEGAJETK-UHFFFAOYSA-N 1-[6-(dimethylamino)naphthalen-2-yl]prop-2-en-1-one Chemical compound C1=C(C(=O)C=C)C=CC2=CC(N(C)C)=CC=C21 HMWAJFNEGAJETK-UHFFFAOYSA-N 0.000 description 2
- MPPQGYCZBNURDG-UHFFFAOYSA-N 2-propionyl-6-dimethylaminonaphthalene Chemical compound C1=C(N(C)C)C=CC2=CC(C(=O)CC)=CC=C21 MPPQGYCZBNURDG-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 101710137500 T7 RNA polymerase Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000003271 compound fluorescence assay Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- VPUGDVKSAQVFFS-UHFFFAOYSA-N coronene Chemical compound C1=C(C2=C34)C=CC3=CC=C(C=C3)C4=C4C3=CC=C(C=C3)C4=C2C3=C1 VPUGDVKSAQVFFS-UHFFFAOYSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- KDTAEYOYAZPLIC-UHFFFAOYSA-N coumarin 152 Chemical compound FC(F)(F)C1=CC(=O)OC2=CC(N(C)C)=CC=C21 KDTAEYOYAZPLIC-UHFFFAOYSA-N 0.000 description 2
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002211 flavins Chemical class 0.000 description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 238000000399 optical microscopy Methods 0.000 description 2
- IJTNSXPMYKJZPR-UHFFFAOYSA-N parinaric acid Chemical compound CCC=CC=CC=CC=CCCCCCCCC(O)=O IJTNSXPMYKJZPR-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000001429 visible spectrum Methods 0.000 description 2
- XJZXHBYIBXUEMY-UHFFFAOYSA-N (2z)-3-propyl-2-[(2z,4z)-5-(3-propyl-1,3-benzothiazol-3-ium-2-yl)penta-2,4-dienylidene]-1,3-benzothiazole Chemical compound S1C2=CC=CC=C2[N+](CCC)=C1C=CC=CC=C1N(CCC)C2=CC=CC=C2S1 XJZXHBYIBXUEMY-UHFFFAOYSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- IZWQPBUIXGHLMT-UHFFFAOYSA-N 4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-n,n-dipentylaniline Chemical compound C1=CC(N(CCCCC)CCCCC)=CC=C1C=CC1=CC=[N+](C)C=C1 IZWQPBUIXGHLMT-UHFFFAOYSA-N 0.000 description 1
- GBPBPEPUZCTZLS-UHFFFAOYSA-M 4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-n,n-dipentylaniline;iodide Chemical compound [I-].C1=CC(N(CCCCC)CCCCC)=CC=C1\C=C\C1=CC=[N+](C)C=C1 GBPBPEPUZCTZLS-UHFFFAOYSA-M 0.000 description 1
- ZKARERKEBVSZCX-VMDDUYISSA-M 4-methylbenzenesulfonate;trimethyl-[4-[(1e,3e,5e)-6-phenylhexa-1,3,5-trienyl]phenyl]azanium Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC([N+](C)(C)C)=CC=C1\C=C\C=C\C=C\C1=CC=CC=C1 ZKARERKEBVSZCX-VMDDUYISSA-M 0.000 description 1
- YERWMQJEYUIJBO-UHFFFAOYSA-N 5-chlorosulfonyl-2-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]benzenesulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(Cl)(=O)=O)C=C1S([O-])(=O)=O YERWMQJEYUIJBO-UHFFFAOYSA-N 0.000 description 1
- VTRBOZNMGVDGHY-UHFFFAOYSA-N 6-(4-methylanilino)naphthalene-2-sulfonic acid Chemical compound C1=CC(C)=CC=C1NC1=CC=C(C=C(C=C2)S(O)(=O)=O)C2=C1 VTRBOZNMGVDGHY-UHFFFAOYSA-N 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- FTEDXVNDVHYDQW-UHFFFAOYSA-N BAPTA Chemical compound OC(=O)CN(CC(O)=O)C1=CC=CC=C1OCCOC1=CC=CC=C1N(CC(O)=O)CC(O)=O FTEDXVNDVHYDQW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010051152 Carboxylesterase Proteins 0.000 description 1
- 102000013392 Carboxylesterase Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101710204837 Envelope small membrane protein Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VWWQXMAJTJZDQX-UHFFFAOYSA-N Flavine adenine dinucleotide Natural products C1=NC2=C(N)N=CN=C2N1C(C(O)C1O)OC1COP(O)(=O)OP(O)(=O)OCC(O)C(O)C(O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UHFFFAOYSA-N 0.000 description 1
- 229930191892 Formycin Natural products 0.000 description 1
- KBHMEHLJSZMEMI-UHFFFAOYSA-N Formycin A Natural products N1N=C2C(N)=NC=NC2=C1C1OC(CO)C(O)C1O KBHMEHLJSZMEMI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930189936 Glyoxalase Natural products 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- LUWJPTVQOMUZLW-UHFFFAOYSA-N Luxol fast blue MBS Chemical compound [Cu++].Cc1ccccc1N\C(N)=N\c1ccccc1C.Cc1ccccc1N\C(N)=N\c1ccccc1C.OS(=O)(=O)c1cccc2c3nc(nc4nc([n-]c5[n-]c(nc6nc(n3)c3ccccc63)c3c(cccc53)S(O)(=O)=O)c3ccccc43)c12 LUWJPTVQOMUZLW-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101710088839 Replication initiation protein Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- HACOCUMLBPNDIN-UHFFFAOYSA-M ac1l2skh Chemical compound [O-]Cl(=O)(=O)=O.C1CCN2CCCC3=C2C1=C1OC2=C(CCC4)C5=[N+]4CCCC5=CC2=C(C#N)C1=C3 HACOCUMLBPNDIN-UHFFFAOYSA-M 0.000 description 1
- RZUBARUFLYGOGC-MTHOTQAESA-L acid fuchsin Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=C(N)C(C)=CC(C(=C\2C=C(C(=[NH2+])C=C/2)S([O-])(=O)=O)\C=2C=C(C(N)=CC=2)S([O-])(=O)=O)=C1 RZUBARUFLYGOGC-MTHOTQAESA-L 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- IJTNSXPMYKJZPR-WVRBZULHSA-N alpha-parinaric acid Natural products CCC=C/C=C/C=C/C=CCCCCCCCC(=O)O IJTNSXPMYKJZPR-WVRBZULHSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- DMMLYDCVMZEUMT-UHFFFAOYSA-N benzo[h]cinnoline Chemical compound C1=NN=C2C3=CC=CC=C3C=CC2=C1 DMMLYDCVMZEUMT-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- GTSMOYLSFUBTMV-UHFFFAOYSA-N ethidium homodimer Chemical compound [H+].[H+].[Cl-].[Cl-].[Cl-].[Cl-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2C(C)=[N+]1CCCNCCNCCC[N+](C1=CC(N)=CC=C1C1=CC=C(N)C=C11)=C1C1=CC=CC=C1 GTSMOYLSFUBTMV-UHFFFAOYSA-N 0.000 description 1
- DSLLHVISNOIYHR-UHFFFAOYSA-M ethyl 2-(6-methoxyquinolin-1-ium-1-yl)acetate;bromide Chemical compound [Br-].COC1=CC=C2[N+](CC(=O)OCC)=CC=CC2=C1 DSLLHVISNOIYHR-UHFFFAOYSA-M 0.000 description 1
- YTPLJUZIOGNPTJ-UHFFFAOYSA-M ethyl 2-isoquinolin-2-ium-2-ylacetate;bromide Chemical compound [Br-].C1=CC=CC2=C[N+](CC(=O)OCC)=CC=C21 YTPLJUZIOGNPTJ-UHFFFAOYSA-M 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- VEPYXRRTOARCQD-IGPDFVGCSA-N formycin Chemical compound N1=N[C]2C(N)=NC=NC2=C1[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O VEPYXRRTOARCQD-IGPDFVGCSA-N 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- YFHXZQPUBCBNIP-UHFFFAOYSA-N fura-2 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=3OC(=CC=3C=2)C=2OC(=CN=2)C(O)=O)N(CC(O)=O)CC(O)=O)=C1 YFHXZQPUBCBNIP-UHFFFAOYSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- DGOBMKYRQHEFGQ-UHFFFAOYSA-M light green sf Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 DGOBMKYRQHEFGQ-UHFFFAOYSA-M 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- DWCZIOOZPIDHAB-UHFFFAOYSA-L methyl green Chemical compound [Cl-].[Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)[N+](C)(C)C)=C1C=CC(=[N+](C)C)C=C1 DWCZIOOZPIDHAB-UHFFFAOYSA-L 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002052 molecular layer Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- WHQSYGRFZMUQGQ-UHFFFAOYSA-N n,n-dimethylformamide;hydrate Chemical compound O.CN(C)C=O WHQSYGRFZMUQGQ-UHFFFAOYSA-N 0.000 description 1
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
- XJCPMUIIBDVFDM-UHFFFAOYSA-M nile blue A Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4[O+]=C3C=C(N)C2=C1 XJCPMUIIBDVFDM-UHFFFAOYSA-M 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000004557 single molecule detection Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- YCUVUDODLRLVIC-VPHDGDOJSA-N sudan black b Chemical compound C1=CC(=C23)NC(C)(C)NC2=CC=CC3=C1\N=N\C(C1=CC=CC=C11)=CC=C1\N=N\C1=CC=CC=C1 YCUVUDODLRLVIC-VPHDGDOJSA-N 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 1
- ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Definitions
- the present invention is directed to compositions and methods for increasing, and detecting the fluorescence of a molecule, in particular, compositions and methods for increasing the intrinsic fluorescence of a biomolecule.
- This invention also is directed to methods and compositions for the detection of biomolecules by increasing and detecting the fluorescence of biomolecules.
- fluorescence detection is widely used in medical testing and DNA analysis because of the high degree of sensitivity obtained using fluorescent techniques.
- Small numbers of molecules can be detected using fluorescence technology.
- extrinsic fluorophores are added covalently or non-covalently to allow molecules that do not ordinarily fluoresce or do not fluoresce at previously commercially useful levels to be detected.
- Biomolecules such as DNA ordinarily do not fluoresce at detectable levels, and extrinsic fluorophores are added to DNA to facilitate the detection of DNA on gels (Benson et al. (1993) Nucleic Acids Res.
- Extrinsic fluorophores are used with DNA because DNA absorbs in the UV region near 260 nm. The short absorption wavelength is now less of an obstacle because UV solid state lasers have become available. Nonetheless, the intrinsic fluorescence from DNA is of little practical usefulness because of the low quantum yields of 10 ⁇ 4 to 10 ⁇ 5 (Vigny et al. (1974) Photochem. Photobiol. 20, 345-349; Morgan et al. (1980) Photochem. Photobiol. 31, 101-113). Because the intrinsic emission from DNA, nucleotides and nucleic acid bases is very weak (Kneipp et al. (1999) Curr.
- RET Resonance Energy Transfer
- immunofluorescent assays and fluorescence in situ hybridization.
- Detection of the molecule of interest is generally limited by the properties of the fluorophore used.
- labeling a biomolecule with an extrinsic fluorophore can alter the biological activity of the biomolecule potentially creating experimental artifacts.
- Problems with current fluorescent techniques stem in part from the low fluorescent intensities of commonly used fluorophores. Additionally, background fluorescence can be significant when using low wavelength excitation radiation required by some fluorophores or when large quantities of fluorophore are required.
- DNA sequencing techniques using fluorescent dyes as markers have their maximum emission spectra in the visible range, the DNA is subject to irradiation in the visible spectra, and visible spectra detectors and light sources are used. Generally photomultipliers tubes are used for detection. As a result, these DNA sequencing techniques have several disadvantages including high costs resulting from the high cost of the lasers used to excite the fluorescent markers which typically emit in the visible region of light spectrum and the high noise to signal ratio due to the background interferences by biomolecules.
- compositions and methods for manipulating the fluorescence emission intensity of a biomolecule in response to an amount of exciting radiation are also present.
- One aspect of the present invention is directed to a biomolecule in combination with a metal particle, wherein the metal particle and the biomolecule are positioned at a distance apart sufficient to enhance intrinsic emission of electromagnetic radiation from the biomolecule in response to an amount of exciting electromagentic radiation.
- biomolecules include, but are not limited to, purines, pyrimidines, nucleic acids, oligonucleotides, peptide nucleic acids, RNA, DNA, amino acids, proteins, peptides, vitamins, lipids, carbohydrates, steroids and antibodies.
- Exemplary metals include, but are not limited to, rhenium, ruthenium, rhodium, palladium, silver, copper, osmium, iridium, platinum, and gold.
- the present invention is predicated on the surprising discovery that the fluorescence intensity of a biomolecule can be manipulated by varying the distance between the biomolecule and a metal particle. It will be appreciated by one of ordinary skill in the art that the scope of the present invention includes increasing the intrinsic fluorescence of a biomolecule as well as the fluorescence of a biomolecule labeled with extrinsic probes.
- the extrinsic fluorescence of a biomolecule includes but is not limited to the fluorescence of a fluorophore conjugated to the biomolecule. Such extrinsic fluorophores can be covalently or non-covalently attached to the biomolecule.
- Other aspects of the present invention describe novel compositions and methods for the detection of biomolecules.
- the present invention overcomes the problems associated with background fluorescence because the signal to noise ratio is increased when the fluorescence intensity of the biomolecule is increased. Additionally, expensive lasers are not required, thereby reducing costs. Extrinsic fluorophores may not be required making fluorescence assays of biomolecules quicker and less expensive.
- Another aspect of the present invention provides a method for increasing the intrinsic fluorescence of a biomolecule including the step of positioning a metal particle and the biomolecule at a distance apart sufficient to increase the electromagnetic emission from the biomolecule in response to an amount of exciting radiation. It will be appreciated that the present invention includes positioning of a biomolecule adjacent to a metal particle or positioning a metal particle adjacent to biomolecule in any of the disclosed embodiments.
- Still another aspect of the present invention provides a method for detecting a biomolecule including the steps of positioning a metal particle and a biomolecule at a distance apart sufficient to manipulate the electromagnetic emission from the biomolecule, exposing the biomolecule to an amount of exciting radiation, and detecting the electromagnetic emission from the biomolecule.
- Yet another aspect provides a method for manipulating fluorescence intensity of a biomolecule including the steps of increasing the rate of radiative decay of the biomolecule by positioning the biomolecule adjacent to a metal particle, and exposing the biomolecule to an amount of exciting radiation. By increasing the rate of radiative decay, the fluorescence intensity of the biomolecule can be increased.
- Another aspect of the present invention discloses a method for detecting the presence of a nucleic acid sequence in a sample including the steps of providing a sample, adding a nucleic sequence linked to a metal particle, exposing the sample to an amount of exciting radiation, detecting the fluorescence, and determining the presence of a nucleic acid sequence based on the detection of the fluorescence.
- Still another aspect provides a method for increasing the fluorescence intensity of a fluorescently labeled biomolecule including the steps of labeling a biomolecule with a fluorophore, positioning the labeled biomolecule next to a metallic particle such that in response to an amount of exciting radiation, the fluorophore emits radiation.
- Yet another aspect provides a method for increasing fluorescence energy transfer on a fluorescently labeled biomolecule including the steps of labeling a first biomolecule with a donor fluorophore and labeling a second biomolecule with an acceptor fluorophore, positioning both the first labeled biomolecule and the second labeled biomolecule adjacent to a metal particle such that in response to an amount of exciting radiation, the donor fluorophore transfers energy to the acceptor fluorophore causing the acceptor fluorophore to emit electromagnetic radiation.
- Another aspect provides a method for increasing fluorescence energy transfer on a fluorescently labeled biomolecule including the steps of labeling a biomolecule with a donor fluorophore and an acceptor fluorophore, positioning the labeled adjacent to a metal particle such that in response to an amount of exciting radiation, the donor fluorophore transfers energy to the acceptor fluorophore causing the acceptor fluorophore to emit electromagnetic radiation.
- Another aspect of the present invention provides a method for increasing the fluorescent intensity of a fluorophore including the steps of positioning a fluorophore adjacent to a metal particle, and exciting the fluorophore with a plurality of photons (this process is referred to as multi-photon excitation).
- Another aspect of the present invention provides a method for increasing the fluorescent intensity of a biomolecule including the steps of positioning a biomolecule adjacent to a metal particle, and exciting the biomolecule with a plurality of photons.
- Yet another aspect of the present invention provides a method for selectively enhancing a region of electromagnetic emission of a sample including the steps of directing a metal particle to a region of interest in the sample, and providing an amount of exciting radiation in the sample.
- Another aspect of the invention provides a method for selectively enhancing the region of electromagnetic emission of a sample including the steps of directing a metal particle to a region of interest in the sample, contacting the sample with a fluorophore, and exposing the sample to an amount of exciting radiation.
- FIGS. 1A and 1B depict silver metal islands on a quartz surface and its absorption spectrum, respectively.
- FIGS. 2 A-C are absorption spectra of rose bengal in a cuvette, between quartz plates, and between quartz slides with silver islands respectively.
- FIGS. 3A, 3B are emission spectra of rhodamine B and rose bengal between silver island films.
- FIGS. 4 A- 4 C are a graphs showing frequency-domain intensity decays of rhodamine B under various conditions.
- FIGS. 5 A- 5 C are graphs showing frequency-domain intensity decays of rose bengal under various conditions.
- FIGS. 6 A- 6 B are reconstructed time-domain intensity decays of rhodamine B and rose bengal.
- FIGS. 7 A- 7 D are emission spectra of Erb, BF, [Ru(bpy) 3 ] 2+ , and [Ru(phen) 2 dppz] 2+ between silver island films (S) and between uncoated quartz plates (Q).
- FIG. 8 is a graphical depiction of the enhancement of the emission of fluorophores having different quantum yields when placed between silver island films.
- FIG. 9 is a graphical depiction of the fluorescence intensity of [Ru(phen) 2 dppz]2+ between silver island films (I s ) compared to the fluorescence intensity between quartz plates (I Q ) in solutions of DMF and water.
- [Ru ⁇ phen ⁇ 2 dppx] 2+ decreases in fluorescence intensity in the presence of water (inset).
- FIG. 9 shows that silver island particles have a greater enhancement (I S /I Q ) on [Ru(phen) 2 dppz] 2+ in solutions having more water than DMF.
- silver island films have a greater enhancement of fluorescence intensity on weak or quenched fluorophores than on strong or non-quenched fluorophores.
- FIGS. 10A and 10B are emission spectra of solvent-sensitive fluorophores between silver island films (S) and between uncoated quartz plates (Q).
- FIGS. 11A and 11B are emission spectra of ⁇ -galactosidase and human glyoxalase between silver island films (S) and between uncoated quartz plates (Q).
- FIGS. 12A and 12B are emission spectra of nucleic acid bases between silver island films (S) and between uncoated quartz plates (Q).
- FIGS. 13A and 13B are emission spectra of single stranded nucleic acids between silver island films (S) and between uncoated quartz plates (Q).
- FIGS. 14A and 14B are absorption spectra of calf thymus DNA in a cuvette ( 14 A) and between silver island films or uncoated quartz plates ( 14 B).
- FIGS. 15A and 15B are the emission spectra of DNA in a cuvette ( 15 A) and between silver island films or uncoated quartz plates ( 15 B).
- FIGS. 16A and 16B are frequency-domain intensity decays of calf thymus DNA in a cuvette ( 16 A) and between silver island films ( 16 B).
- FIG. 17 is time dependent intensity decays of calf thymus DNA between silver island films and in a cuvette.
- FIG. 18 is emission spectra of R6G as donor and SR101 as acceptor between uncoated quartz plates and between silver island films.
- FIG. 19 is emission spectra of DNA labeled with DAPI and acridine orange between silver island films and between uncoated quartz plates.
- FIG. 20 is emission spectra of DNA labeled with DAPI alone; with propidium iodide (PI) alone; or with DAPI and PI between uncoated quartz plates.
- FIG. 21 is emission spectra of DAPI-labeled DNA and PI-labeled DNA between silver island films and between uncoated quartz plates.
- FIG. 22 is emission spectra of DNA labeled with both DAPI and PI between silver island films and between uncoated quartz plates.
- FIGS. 23 A- 23 C are frequency-domain intensity decays of the DAPI donor decay for calf thymus DNA labeled with both DAPI and PI in a cuvette ( 23 A), between uncoated quartz plates ( 23 B), and between silver islands ( 23 C). The frequency-domain intensity decay of DAPI alone is also shown.
- FIGS. 24 A- 24 C are the frequency-domain intensity decays of DAPI in calf thymus DNA labeled with both DAPI and PI in a cuvette ( 24 A), between uncoated quartz plates ( 24 B), and between silver islands ( 24 C).
- FIG. 25 is an exemplary geometry for detecting fluorophores between silver island films.
- FIGS. 26A and 26B are emission spectra of rhodamine B between silver island films and uncoated quartz plates using one-photon excitation and two photon excitation.
- FIG. 27 emission spectra of rhodamine B with two photon excitation between uncoated quartz plates and between quartz plates with silver islands on the outer surface of the quartz plates.
- FIGS. 28A and 28B are frequency-domain intensity decays of rhodamine B with one photon excitation between uncoated quartz plates ( 28 A) and between silver island films ( 28 B).
- FIGS. 29A and 29B are frequency-domain intensity decays of rhodamine B with two photon excitation between uncoated quartz plates ( 29 A) and between silver island films ( 29 B).
- FIGS. 30A and 30B are graphs depicting the photostability of rhodamine B between uncoated quartz plates (Q) and between silver island films (S).
- FIGS. 31A and 31B are emission spectra of eosin ( 31 A) and rose bengal ( 31 B) between uncoated quartz plates (Q) and between silver island films (S) using two photon excitation.
- FIGS. 32A and 32B are emission spectra of coumarin ( 32 A) between uncoated quartz plates (Q) and between silver island films (S) and ANS ( 32 B) in a cuvette (C), between uncoated quartz plates (Q), and between silver island films (S).
- FIG. 33 is a depiction of selective multi-photon excitation of fluorophores on metal colloids in the presence of free fluorophore.
- FIG. 34 is a depiction of localized multi-photon excitation of intracellular autofluorescence by metal colloids.
- FIG. 35 is an exemplary embodiment of a sandwich immunoassay in conjunction with a silver island coated surface.
- FIGS. 36 A-C are an exemplary embodiment of voltage-activated fluorescence assays.
- FIGS. 37 A-C are an exemplary embodiment of an energy transfer immunoassay using donor and acceptor-labeled antibodies.
- FIG. 38A is an exemplary apparatus for surface plasmon excitation and FIG. 38B is a graph of the angular distribution of the fluorescence from rhodamine 6G.
- fluorophore means any substance that emits electromagnetic energy such as light at a certain wavelength (emission wavelength) when the substance is illuminated by radiation of a different wavelength (excitation wavelength).
- Extrinsic fluorophores refers to fluorophores bound to another substance.
- Intrinsic fluorophores refers to substances that are fluorophores themselves. Exemplary fluorophores include but are not limited to those listed in the Molecular Probes Catalogue which is incorporated by reference herein.
- fluorophores include but are not limited to Alexa Fluor® 350, dansyl Chloride (DNS-Cl), 5-(iodoacetamida)fluoroscein (5-IAF); fluoroscein 5-isothiocyanate (FITC), tetramethylrhodamine 5- (and 6-)isothiocyanate (TRITC), 6-acryloyl-2-dimethylaminonaphthalene (acrylodan), 7-nitrobenzo-2-oxa-1,3,-diazol-4-yl chloride (NBD-Cl), ethidium bromide, Lucifer Yellow, 5-carboxyrhodamine 6G hydrochloride, Lissamine rhodamine B sulfonyl chloride, Texas RedTM sulfonyl chloride, BODIPYTM, naphthalamine sulfonic acids including but not limited to 1-anilinonaphthalene-8-sulfonic acid (ANS) and 6-(p-
- Representative intrinsic fluorophores include but are not limited to organic compounds having aromatic ring structures including but not limited to NADH, FAD, tyrosine, tryptophan, purines, pyrimidines, lipids, fatty acids, nucleic acids, nucleotides, nucleosides, amino acids, proteins, peptides, DNA, RNA, sugars, and vitamins. Additional suitable fluorophores include enzyme-cofactors; lanthanide, green fluorescent protein, yellow fluorescent protein, red fluorescent protein, or mutants and derivates thereof.
- biomolecule means any carbon based molecule occurring in nature or a derivative of such a molecule.
- the biomolecule can be in active or inactive form.
- Active form means the biomolecule is in a form that can perform a biological function.
- Active form means the biomolecule must be processed either naturally or synthetically before the biomolecule can perform a biological function.
- biomolecules include nucleic acids, aromatic carbon ring structures, NADH, FAD, amino acids, carbohydrates, steroids, flavins, proteins, DNA, RNA, oligonucleotides, peptide nucleic acids, fatty acids, sugar groups such as glucose etc., vitamins, cofactors, purines, pyrimidines, formycin, lipids, phytochrome, phytofluor, and phycobiliproptein.
- the term “amount of exciting radiation” means an amount of radiation that causes a molecule to emit radiation.
- One embodiment of the present invention is directed to a biomolecule in combination with a metal particle, wherein said metal particle and the biomolecule are positioned at a distance apart sufficient to adjust, preferably enhance, intrinsic emission of electromagnetic radiation from the biomolecule in response to an amount of exciting electromagnetic radiation.
- exemplary biomolecules include but are not limited to purines, pyrimidines, nucleic acids, oligonucleotides, peptide nucleic acids, RNA, DNA, amino acids, flavins, proteins, peptides, vitamins, lipids, antibodies, and aromatic carbon ring structures.
- Preferred biomolecules and fluorophores of the present invention have quantum yields of less than about 0.8, more preferably of less than about 0.5, and most preferably of less than about 0.2.
- Exemplary metals include copper and noble metals such as rhenium, ruthenium, rhodium, palladium, silver, osmium, iridium, platinum, and gold.
- another embodiment provides a composition of matter including a biomolecule in combination with a metal surface wherein said metal surface and the biomolecule are positioned at a distance apart sufficient to adjust, preferably enhance, intrinsic emission of electromagnetic radiation from the biomolecule in response to an amount of exciting electromagnetic radiation.
- the metal surface can be a periodic metal surface.
- the present invention is predicated on the surprising discovery that the fluorescence intensity of a biomolecule can be manipulated by varying the distance between the biomolecule and a metal particle. Indeed, it has been discovered that the intrinsic fluorescence of a biomolecule can be increased by at least about 80 fold to about 140 fold when the biomolecule is positioned adjacent to a metal particle. Preferably the metal particle and biomolecule are separated by a distance of about 50 ⁇ to about 2000 ⁇ , most preferably from about 50 ⁇ to about 200 ⁇ . In another embodiment, the metal particle is sub-wavelength in size, typically in the range of about 50 ⁇ to about 300 ⁇ . The metal particles can be spheroid, ellipsoid, or of any other geometry.
- the metal particles can be suspended in a colloid or combination of colloids, alloys, or combinations of more than one metal.
- the metal particles can be placed on surfaces as thin films, or deposited on surfaces to form small islands.
- the surfaces can be metallic or non-metallic.
- the metal particles can be coated with polymers, gels, adhesives, oxides, or biologic material. Exemplary coatings include substances that increase the binding of the metal particle to surfaces or other molecules.
- the metal particles can be modified on its surface to facilitate binding to non-metallic molecules and biomolecules.
- metal particles, preferably noble metals, most preferably silver are chemically reduced on a surface. Chemical reduction can be accomplished using known techniques.
- Exemplary surfaces include but are not limited to glass or quartz.
- the biomolecule and the metal particle can be attached to each other via an intermediate of a length sufficient to have a desired effect on the intrinsic fluorescence of the biomolecule.
- the attachment can be covalent or non-covalent.
- the metal and biomolecule can be stably linked or can be linked such that the two can become separated as a result of a chemical reaction, enzymatic reaction, or photoreaction.
- a biomolecule linked to a metal particle can be internalized within a cell, cellular organelle, or other compartment. Once internalized, the linked biomolecule can be subjected to enzymatic or chemical reaction resulting in the complete separation of the metal particle from the biomolecule.
- Exemplary enzymatic reactions include, but are not limited to, non-specific esterase reactions, and exemplary chemical reactions include but are not limited to hydrolysis, oxidation, or substitution.
- the biomolecule can become undetectable or less detectable because its intrinsic fluorescence is no longer amplified by the metal particle. If the intrinsic fluorescence of the biomolecule is desired to be quenched, the biomolecule and the metal particle can be separated by a distance of about 0 to less than 50 ⁇ . If the intrinsic fluorescence of the biomolecule is to be increased, the biomolecule and the metal particle can be separated by a distance of about 50 ⁇ to about 2000 ⁇ , more preferably from about 50 ⁇ to about 200 ⁇ . Thus, the fluorescence intensity of a biomolecule can be manipulated by varying the distance separating the metal particle from the biomolecule.
- the scope of the present invention includes increasing the extrinsic fluorescence of a biomolecule as well as the intrinsic fluorescence of the biomolecule.
- the extrinsic fluorescence of a biomolecule includes but is not limited to the fluorescence of a fluorophore conjugated to the biomolecule.
- conjugated fluorophores can be covalently or non-covalently attached to the biomolecule.
- An increase or decrease in fluorescence intensity in the present invention means an increase or decrease in intrinsic or extrinsic fluorescence intensity when the biomolecule or fluorophore is in combination with a metal particle compared to the intrinsic or extrinsic fluorescence intensity of the biomolecule or fluorophore in the absence of a metal particle.
- Another embodiment of the present invention provides a method for increasing the intrinsic fluorescence of a biomolecule including the step of positioning the biomolecule and a metal particle at a distance apart sufficient to increase the electromagnetic emission from the biomolecule in response to an amount of exciting radiation.
- the present invention includes positioning of a biomolecule adjacent to a metal particle or positioning a metal particle adjacent to the biomolecule in any of the disclosed embodiments.
- the biomolecule and the metal particle are separated by a distance of about 50 ⁇ to about 2000 ⁇ , preferably from about 50 ⁇ to about 200 ⁇ , to increase the intrinsic fluorescence of the biomolecule or separated by a distance of less than about 50 ⁇ if the intrinsic fluorescence is to be quenched.
- the metal particles can be fixed on a surface, and the biomolecule positioned adjacent to such a surface. Such surfaces can form a part of cuvette or can be an insert capable of being placed within a cuvette.
- Linkers can be one intervening atom or molecule, preferably carbon chains of at least one carbon atom. Other linkers include but are not limited to at least one amino acid. Additionally, other chemical linkers known in the art can be used. The linkers can be of any length, preferably of up to about 200 ⁇ depending the desired effect on fluorescence.
- the metal particle can be positioned adjacent to the biomolecule using electromagnetic forces, charged fields, gravity or other known methods. In one example, voltage can be regulated to manipulate the position of the metal particle, or linked biomolecule and metal particle. Alternatively, the biomolecule can be positioned using electromagnetic fields, electric currents, voltage, or gravity.
- Yet another embodiment of the present invention provides a method for detecting a biomolecule including the steps of positioning said biomolecule and a metal particle at a distance apart sufficient to manipulate the electromagnetic emission from the biomolecule, exposing the biomolecule to an amount of exciting radiation, and detecting the electromagnetic emission from the biomolecule.
- Monitoring, detecting, and quantifying fluorescence is known in the art. See for example Joseph R. Lakowicz. Principles in Fluorescence Spectroscopy, Plenum Publishers 1999 which is incorporated by reference herein in its entirety.
- fluorescence can be detected using devices including, but not limited to, a spectrofluorometer having a light source and detector.
- Light sources can include arc lamps and lasers.
- Detectors can include photomultiplier tubes.
- the fluorescence intensity of a biomolecule can be increased in response to an amount of exciting radiation when the distance between the metal particle and the biomolecule is from about 50 ⁇ to about 2000 ⁇ , preferably from about 50 ⁇ to about 200 ⁇ .
- the fluorescence intensity of the biomolecule can be reduced when the distance between the biomolecule and the metal particle is less than about 50 ⁇ .
- Yet another embodiment provides a method for manipulating fluorescence intensity of a biomolecule including the steps of increasing the rate of radiative decay of the biomolecule by positioning the biomolecule adjacent to a metal particle, and exposing the biomolecule to an amount of exciting radiation. By increasing the rate of radiative decay, the fluorescence intensity of the biomolecule can be increased. It has been discovered that by manipulating the distance separating a biomolecule and a metal particle, the radiative decay of the biomolecule can also be manipulated.
- Another embodiment of the present invention discloses a method for detecting the presence of a nucleic acid sequence in a sample including the steps of providing a sample, adding a nucleic sequence linked to a metal particle, exposing the sample to an amount of exciting radiation, detecting the fluorescence, and determining the presence of the nucleic acid sequence based on the detection of the fluorescence.
- the nucleic acid sequence linked to a metal particle is single stranded. In other embodiments, the nucleic acid sequence linked to the metal particle is double stranded.
- the nucleic acid sequence linked to a metal particle is less than two hundred base pairs in length, more preferably, less than 100 base pairs in length, most preferably less than 50 base pairs in length, even more preferably, about twenty or less nucleic acids in length.
- the nucleic acids can be deoxyribonucleic acids, ribonucleic acids, or chemically modified nucleic acids such as peptide nucleic acids and the like.
- nucleic acid sample is separated in an agarose gel based on size and affixed to a membrane, denatured, and exposed to the labeled nucleic acid probe under hybridizing conditions.
- probes used in Southern blots have been labeled with radioactivity, fluorescent dyes, digoxygenin, horseradish peroxidase, alkaline phosphatase and acridinium esters.
- the present invention discloses a novel method for the detection of nucleic acid sequences by increasing the intrinsic fluorescence of the nucleic acids. This increase is accomplished by linking the nucleic acid to a metal, preferably a noble metal.
- the present invention does not require the use of an extrinsic probe. Rather when the nucleic acid sequence linked to a metal particle is added to a sample, this sequence can hybridize to complementary nucleic acid sequences in the sample.
- the nucleic acid sequence to be detected can be affixed to a solid support.
- Exemplary solid supports include films, membranes, columns, nitrocellulose, plastic, quartz, glass, or metal. The sample is irradiated with an amount of exciting radiation.
- Fluorescence detected in the sample or, for example, on the solid support would indicate that the nucleic acid linked to the metal particle has hybridized to a complementary nucleic acid sequence present in the sample. Therefore, the sample contains the nucleic acid sequence of interest. Nucleic acids not linked to a metal particle would not contribute significantly to fluorescence emission because the quantum yield of nucleic acids is too low. It will be appreciated that the nucleic hybridization detected by the present invention can occur in situ. Additionally, it will be appreciated that the detection of the nucleic acid can be based on increasing the fluorescence intensity of an extrinsic fluorophore attached to a nucleic acid by positioning the fluorophore adjacent to a metal particle. Increasing the intrinsic fluorescence of nucleic acids can be useful in DNA arrays or gene chips.
- the present invention provides a method for identifying nucleic acids, the method including the steps of positioning a nucleic acid adjacent to a metal particle, irradiating the nucleic acid, detecting the fluorescence emission from the nucleic acid, and identifying the nucleic acid based on the fluorescence emission.
- the identification of nucleic acids using the intrinsic fluorescence of the nucleic acid eliminates the requirement for extrinsic probes.
- the background fluorescence is not problematic because the intrinsic fluorescence can be increased by about 80 fold thereby reducing the noise to signal ratio.
- the nucleic acid can be identified based on the emission spectra obtained from monitoring the fluorescence of the sample.
- the sequence of nucleic acids in a sample can be determined by sequentially removing a nucleic acid, positioning the nucleic acid adjacent to metal particle, irradiating the nucleic acid with an amount of exciting radiation, detecting the emitted radiation, and correlating the emitted radiation with the nucleic acid base.
- Methods for sequentially removing a single nucleic acid form a nucleic acid sequence such as an oligonucleotide are known in the art and include sequential digestion, hydrolysis, and chemical cleavage.
- the nucleic acids can be positioned adjacent to a metal particle by causing the stream of a fluid sample containing a nucleic acid to pass near a surface containing the metal particle.
- Such surfaces can be thin films or islands of metal that form part of a sample chamber.
- the irradiation of the nucleic acid can be timed to coincide with the positioning of the nucleic acid adjacent to the metal.
- the nucleic acids can be irradiated with one or more wavelengths.
- the nucleic acids are excited at wavelengths below 300 nm, preferably from 280 to about 295 nm.
- the excitation wavelength is near 520 nm for multi-photon excitation.
- compositions of the present invention can be used in polymerase chain reaction techniques.
- Polymerase chain reaction techniques are will known in the art.
- Nucleic acids coupled to metal particles, preferably noble metal particles, can be added to the polymerase chain reaction mixtures.
- the coupled nucleic acids can be incorporated into the growing oligonucleotide chain, and in response to an amount of exciting radiation, the fluorescence of the coupled nucleic acid will be detectable enabling the detection of the polymerase chain reaction product.
- Still another embodiment provides a method for increasing the fluorescence intensity of a fluorescently labeled biomolecule including the steps of labeling a biomolecule with a fluorophore, positioning the labeled biomolecule adjacent to a metallic particle such that in response to an amount of exciting radiation, the fluorophore emits radiation, preferably detectable amounts of radiation.
- the fluorophore has a quantum yield of less than 0.8, preferably less than 0.5, more preferably less than 0.2, and most preferably less than 0.1.
- the fluorescence intensity of an extrinsic fluorophore can be used to detect the biomolecule.
- Yet another embodiment provides a method for increasing fluorescence energy transfer on a fluorescently labeled biomolecule including the steps of labeling a first biomolecule with a donor fluorophore and labeling a second biomolecule with an acceptor fluorophore, positioning the labeled biomolecules adjacent to a metal particle such that in response to an amount of exciting radiation, the donor fluorophore transfers energy to the acceptor fluorophore causing the acceptor fluorophore to emit electromagnetic radiation.
- Another embodiment provides a method for increasing fluorescence energy transfer on a fluorescently labeled biomolecule including the steps of labeling a biomolecule with a donor fluorophore and an acceptor fluorophore, positioning the labeled adjacent to a metal particle such that in response to an amount of exciting radiation, the donor fluorophore transfers energy to the acceptor fluorophore causing the acceptor fluorophore to emit electromagnetic radiation.
- compositions of the present invention can use fluorescence energy transfer to measure an affinity reaction, preferably an antibody-antigen reaction or a protein-carbohydrate interaction.
- assay chambers coated with or containing metallic particles can be used to increase the efficiency or RET even between donor and acceptors to span distances over 100 ⁇ apart.
- Metal enhanced energy transfer is also useful with DNA arrays or gene chips.
- the compositions and methods of the present invention can utilize fluorescence energy transfer to measure DNA hybridization or the amount of double helical DNA. At present the arrays are read by measuring the amount of two fluorophores hybridized to the target DNA (Ferea et al.
- RNA is prepared from a sample or samples to determine the pattern of gene expression. These samples can be different cell lines, tumor samples, normal vs. disease, control or drug-treated, etc.
- polyA+RNA In most cases, a minimum of about 1 ⁇ g of polyA+RNA or about 5 ⁇ g of total RNA is required. However, as little as 0.2 ⁇ g of “good quality” polyA+RNA can be used. As a general rule, 1 ⁇ 10 6 tissue culture cells should yield 10-15 ⁇ g of total RNA.
- the RNA is converted into cDNA.
- the cDNA can be labeled directly by incorporation of fluorescently-tagged dNTPs. More commonly, the cDNA is prepared using an oligo-dT primer that incorporates a T7 RNA polymerase promoter. The cDNA is then used in a subsequent step to make fluorescently-tagged copy RNA, using T7 RNA polymerase. In general, at least about 5 ⁇ g of labeled cRNA or cDNA is required for hybridizing to each microarray. However, the probes can be reused. For example, one labeled probe can be used sequentially to hybridize to five separate arrays.
- the fluorescently-labeled probes are hybridized to the microarrays, much as radioactive probes are hybridized to conventional dot-blots.
- the fluorescence of the labeled probe will increase in response to an amount of exciting radiation when the probe hybridizes to a complementary sequence because it is positioned near the metal microarray surface, preferably from about 50 ⁇ to about 2000 ⁇ , more preferably from about 50 ⁇ to about 200 ⁇ , from the metal surface.
- the probe can be labeled with a donor and an acceptor fluorophore.
- the labeled probe When the labeled probe hybridizes to its complement on the microarray surface, it is positioned near the metal microarray surface, preferably from about 50 ⁇ to about 2000 ⁇ , more preferably from about 50 ⁇ to about 200 ⁇ , from the metal surface. In this position, the fluorescence energy transfer from the donor to the acceptor molecule is increased in response to an amount of exciting radiation enabling detection of the labeled probe. Detection of the labeled probe on the microarray indicates that the probe has hybridized to a complementary sequence further indicating expression of the corresponding gene.
- the nucleic acid sequence affixed to the metal coated microarray surface can be labeled with a donor or acceptor molecule, and the nucleic acid probe can be labeled with acceptor or donor molecule respectively such that when the nucleic acid probe hybridizes with a labeled nucleic acid sequence on the microarray surface, the fluorescence energy transfer from the donor molecule to the acceptor molecule is increased in response to an amount of exciting radiation.
- the microarrays are analyzed using a fluorescent scanner: a cross between a typical flat-bed scanner and a confocal microscope.
- the data is an image of the fluorescent spots on the microarray.
- the image can be analyzed using software that identifies the spots and calculates the intensity of the fluorescence in each one. By comparing the intensities obtained with two different probes (e.g. control vs. drug-treated), one can determine how the expression of each gene in the array changes.
- proteins can be arrayed on metal surfaces, preferably noble metal surfaces, most preferably silver coated surfaces.
- a GMS 417 Arrayer (Affymetrix, Santa Clara, Calif.) or other suitable device can be used.
- the arrayer picks up about a microliter of sample from four wells of a 96- or 384-well plate and deposits about 1 nanoliter of each sample at defined locations on a series of glass microscope slides.
- the arrayer can use a pin and ring system: the samples are picked up in small rings that each hold about 1 microliter and a solid pin (150 ⁇ m diameter) then punches repeatedly through the ring to deposit the proteins on the slides.
- 40% glycerol is included in the protein samples. Nanoliter droplets of 40% glycerol remain hydrated, even when left exposed to the atmosphere overnight.
- BSA-NHS slides that are fabricated by first attaching a molecular layer of BSA to the surface of glass slides and then activating the BSA with N,N′-disuccinimidyl carbonate are used. The activated lysine, aspartate, and glutamate residues on the BSA react readily with surface amines on the proteins to form covalent urea or amide linkages. The slides are then quenched with glycine.
- Aldehyde slides can be purchased from TeleChem International (Cupertino, Calif.).
- BSA-NHS slides displaying activated amino and carboxyl groups on the surface of an immobilized layer of bovine serum albumin (BSA), can be fabricated as follows. 10.24 g N,N′-disuccinimidyl carbonate (100 mM) and 6.96 ml N,N-diisopropylethylamine (100 mM) were dissolved in 400 ml anhydrous N,N-dimethylformamide (DMF).
- 30 CMT-GAP slides Corning Incorporated, Coming, N.Y.), displaying amino groups on their surface, were immersed in this solution for 3 hours at room temperature.
- the slides are rinsed twice with 95% ethanol and then immersed in 400 ml of phosphate buffered saline (PBS), pH 7.5 containing 1% BSA (w/v) for 12 hour at room temperature.
- PBS phosphate buffered saline
- the slides are rinsed twice with ddH 2 O, twice with 95% ethanol, and centrifuged at 200 g for 1 min to remove excess solvent.
- the slides are then immersed in 400 ml DMF containing 100 mM N,N′-disuccinimidyl carbonate and 100 MM N,N-diisopropylethylamine for 3 hour at room temperature.
- the slides are rinsed four times with 95% ethanol and centrifuged as above to yield BSA-NHS slides.
- the slides are stored in a desiccator under vacuum at room temperature for up to two months without noticeable loss of activity.
- Proteins are dissolved in 40% glycerol, 60% PBS, pH 7.5 at a concentration of 100 ⁇ g/ml unless indicated otherwise.
- the proteins are spotted on aldehyde slides using a GMS 417 Arrayer (Affymetrix, Santa Clara, Calif.). Following a 3 hours incubation in a humid chamber at room temperature, the slides are inverted and dropped onto a solution of PBS, pH 7.5 containing 1% BSA (w/v). After 1 minute, the slides were turned right side up and immersed in the BSA solution for 1 hour at room temperature with gentle agitation. Following a brief rinse in PBS, the slides are ready for further processing.
- Proteins of interest can be labeled with a fluorophore and hybridized to the array.
- the fluorescence of the fluorophore will increase in response to an amount of exciting radiation when the labeled protein is near the metal surface, preferably form about 50 ⁇ to about 2000 ⁇ , more preferably from about 50 ⁇ to about 200 ⁇ , from the metal surface.
- the protein probe of interest can be labeled with an acceptor and donor fluorophore such that when the protein probe binds to a protein on the microarray, the protein probe is positioned near the metal surface such that fluorescence energy transfer is increased from the donor to the acceptor molecule.
- the protein affixed to the metal coated microarray surface can be labeled with a donor or acceptor molecule, and the protein probe can be labeled with acceptor or donor molecule respectively such that when the protein probe hybridizes with a labeled protein on the microarray surface, the fluorescence energy transfer from the donor molecule to the acceptor molecule is increased in response to an amount of exciting radiation.
- a microarray system including a solid support, wherein the solid support is coated with metal particles, preferably noble metal particles, most preferably with silver particles; and a matrix having an array of biomolecules, preferably nucleic acids or amino acids, at desired lengths attached to the support such that when a labeled probe hybridizes to a sequence of the biomolecules, preferably such that the label is positioned about 50 ⁇ to about 2000 ⁇ , preferably from about 50 ⁇ to about 200 ⁇ from a metal particle, the fluorescence of the labeled probe is increased in response to an amount of exciting radiation.
- metal particles preferably noble metal particles, most preferably with silver particles
- a matrix having an array of biomolecules, preferably nucleic acids or amino acids, at desired lengths attached to the support such that when a labeled probe hybridizes to a sequence of the biomolecules, preferably such that the label is positioned about 50 ⁇ to about 2000 ⁇ , preferably from about 50 ⁇ to about 200 ⁇ from a metal particle, the flu
- probe includes proteins, nucleic acids, amino acids, oligonucleotide, peptide nucleic acids, peptides, or other molecules that hybridize, bind, or are complementary to the molecules of the matrix attached to the metal coated surface of the microarray.
- Another embodiment of the present invention provides a method for increasing the fluorescent intensity of a fluorophore including the steps of positioning a fluorophore adjacent to a metal particle, and exciting the fluorophore with a plurality of photons, commonly referred to as multi-photon excitation.
- the fluorophore is excited with short picosecond or fentosecond laser pulses with a wavelength approximately twice the longest single photon absorption maximum.
- Multi-photon excitation instrumentation and methodology are known in the art, and can be found, for example, in Topics in Fluorescence Spectroscopy , Volume 5, Nonlinear and Two-Photon-Induced Fluorescence , Edited by Joseph R. Lakowicz.
- multi-photon excitation is typically performed with a strongly focused laser light source, such as, a mode-locked titanium sapphire laser, providing pulses approximately 100 fentoseconds long, repetition rate near 80 MHz, with a wavelength range from 700 to 900 nm. Multi-photon excitation can also be accomplished with picosecond dye lasers.
- a strongly focused laser light source such as, a mode-locked titanium sapphire laser, providing pulses approximately 100 fentoseconds long, repetition rate near 80 MHz, with a wavelength range from 700 to 900 nm.
- Multi-photon excitation can also be accomplished with picosecond dye lasers.
- Another embodiment of the present invention provides a method for increasing multi-photonic fluorescent intensity of a biomolecule including the steps of positioning a biomolecule adjacent to a metal particle, and exciting the biomolecule with a plurality of photons.
- Yet another embodiment of the present invention provides a method for selectively enhancing the region of electromagnetic emission of a sample including the steps of directing a metal particle to a region of interest in the sample, and providing an amount of exciting radiation in the sample.
- Another embodiment of the invention provides a method for selectively enhancing the region of electromagnetic emission of a sample including the steps of directing a metal particle to a region of interest in the sample, contacting the sample with a fluorophore, exposing the sample to an amount of exciting radiation.
- exemplary metals are noble metals.
- the metal particle can be positioned using electric potential, magnetisim, or gravity.
- Still another embodiment provides a method for selectively enhancing the region of electromagnetic emission of a sample, the method including the steps of directing a metal particle to a region of interest in the sample, providing an amount of exciting radiation in the region of interest.
- Samples can be living cells, tissues, organs, or fluid samples in containers.
- the metal particle can be positioned using electromagnetic fields, or the metal particle can be linked to a protein, antibody, nucleic acid or the like.
- An antibody linked to a metal particle can be used to bring the metal adjacent to molecules recognized by the antibody.
- the metal can be positioned next to such biomolecule such that the fluorescence intensity of the biomolecule will increase in response to an amount of exciting radiation.
- Another embodiment discloses a method for selectively enhancing the region of electromagnetic emission of a sample, said method including the steps of directing a metal particle to a region of interest in the sample, contacting the sample with a fluorophore, and exposing the sample to an amount of exciting radiation.
- the fluorophore has a quantum yield of less than 0.8, preferably less than 0.5, more preferably less than 0.2, and most preferably less than 0.1. Fluorophores with low quantum yields will not fluoresce detectably unless they are adjacent to a metal particle. Thus, when the sample is exposed to an amount of exciting radiation, only the fluorophores adjacent to a metal particle will fluoresce enough to be detectable.
- Still another embodiment discloses a kit for detecting the presence of an analyte comprising an antibody capable of binding to said analyte, the antibody linked to a fluorophore having a quantum yield of less than about 0.5, preferably less than about 0.2, most preferably less than about 0.1, and at least one quartz surface having metal islands deposited thereon.
- exemplary antibodies are directed to proteins, peptides, and other biomolecules.
- Another embodiment discloses a method for detecting an analyte, the method including the steps of labeling a first antibody with a donor, labeling a second antibody with an acceptor, contacting a sample with the first and second antibodies to form a complex with the analyte, positioning the analyte about 50 to about 2000 ⁇ , preferably from about 50 ⁇ to about 200 ⁇ , from a metal particle, preferably a noble metal, providing an amount of exciting radiation, and detecting the analyte based on the increase in energy transfer from donor to acceptor.
- exemplary donors are fluorophores with wavelengths which overlap the absorption spectra of the acceptor.
- Exemplary acceptors have absorption spectra which overlap with the emission spectra of the donors. Acceptors may also be fluorescent. Exemplary donor-acceptor pairs include fluorescein-rhodimine, DAPI-propidium iodide, and Cy3-Cy5.
- the antibodies can be labeled using standard techniques. In one embodiment, the complex can be positioned using gravity, electric potential, or other known force.
- Metal particles or metal particle films are known and can be produced using known methods. The following example uses silver but it will be appreciated that any metal can be used, preferably noble metals. Chemicals used to generate silver particles, silver nitrate (99+%), sodium hydroxide (pellets, 97%), ammonium hydroxide (NH 3 content 28-39%), and D-glucose (99.5%) were purchased from commercial suppliers and used without further purification. All procedures were performed using distilled water which was further purified by Millipore filtration. Silver islands were formed on quartz microscope slides. Quartz provided UV transmission and less autofluorescence. The quartz slides used to deposit silver particles were soaked in a 10:1 (v/v) mixture of H 2 SO 4 (95-98%) and H 2 O 2 (30%) overnight before the deposition. They were washed with water and air-dried prior to use.
- Silver deposition was carried out in a clean 30-ml beaker equipped with a Teflon-coated stir bar.
- a fast stirring silver nitrate solution (0.22 g in 26 ml of Millipore filtered water)
- eight drops of fresh 5% NaOH solution was added. Dark-brownish precipitates were formed immediately. Less than 1 ml of ammonium hydroxide was then added drop by drop to redissolve the precipitates.
- the clear solution was cooled to 5° C. by placing the beaker in an ice bath, followed by soaking the cleaned and dried quartz slides in the solution. At 5° C., a fresh solution of glucose (0.35 g in 4 ml of water) was added. The mixture was stirred for 2 min at that temperature.
- the beaker was removed from the ice bath.
- the temperature of the mixture was allowed to warm up to 30° C.
- the color of the mixture turning from yellow-greenish to yellow, the color of the slides become greenish, the slides were removed and washed with water and bath sonicated for 1 min at room temperature. After being rinsed with water several times, the slides were stored in water for several hours prior to the experiments.
- Emission spectra were obtained using a SLM 8000 spectrofluorometer. Intensity decays were measured in the frequency-domain using instrumentation described previously (Lakowicz et al. (1985) Biophys. Chem. 21, 61-78; Laczko et al. (1990) Rev. Sci. Instrum. 61, 2331-2337).
- R6G rhodamine 6G
- RB rose bengal
- the excitation was at 514 nm from the approximate 78 MHz output of a mode-locked argon ion laser.
- the emission was observed through a 580 interference filter.
- FIG. 1A shows the experimental geometry of the silver islands on quartz slides
- FIG. 1B shows the absorption spectra of silver island films. This spectrum indicates that the particles are sub-wavelength in size.
- the absorption maximum due to this plasmon resonance is expected to be near 380 DM (Kerker, M. (1985) J. Colloid Interface Sci. 105, 297-314; Mulvaney, P. (1996) Langmuir, 12, 788-800).
- the absorption maximum above 400 nm can be due to an asymmetric effective shape of the particles with an axial ratio near 1.5 to 1.0 (Kerker, M. (1985) J. Colloid Interface Sci.
- RhB rhodamine B
- RB rose bengal
- Q uncoated quartz plates
- S silver island films
- RhB and rose bengal The effects of silver islands on the intensity decays of RhB and rose bengal can be seen in the time-resolved decays reconstructed from the frequency-domain data (FIGS. 6A and 6B).
- the intensity decay shows long decay time components essentially identical to the values observed in cuvettes.
- Silver islands result in the appearance of short decay times.
- the larger contribution of the short decay times for rose bengal can be understood from its lower quantum yield in bulk solution.
- RhB has a higher quantum yield so that its emission is detected from molecules throughout the 1 ⁇ m thick sample.
- Rose bengal has a low quantum yield in solution so the observed emission is mostly due to rose bengal molecules near the silver islands. The results from RhB and rose bengal were consistent with expectations.
- FIG. 8 The enhancements for 10 different fluorophore solutions are shown in FIG. 8. In all cases lower bulk-phase quantum yields result in larger enhancements for samples between silver island films. Additionally, [Ru(phen) 2 dppz] 2+ in water-dimethylformamide (DMF) mixtures were examined (FIG. 9). This compound is quenched by water and the largest enhancements were observed for the most-quenched solution (FIG. 9).
- FIGS. 7 - 9 provide strong support for the assertion that proximity of the fluorophore to the metal islands resulted in increased quantum yields. It is unlikely that these diverse fluorophores would all bind to the silver islands or display other unknown effect results which resulted in enhancements with increased monotonically with decreased quantum yields.
- FIGS. 10A and 10B show the emission spectra of two solvent sensitive fluorophores between quartz plates (Q) and silver islands (S). In both cases blue shifts in the emission, which are consistent with a decreased lifetime of fluorophores near the islands were observed. Because fluorophores within 50 ⁇ of the metal are likely to be quenched, it is unlikely that the blue shifts seen in FIG. 10A and FIG. 10B are due to fluorophores bound to the silver islands. Binding of fluorophores to the uncoated quartz surface is also unlikely because uncoated quartz is present for both emission spectra.
- the protein E. coli ⁇ -galactosidase and human glycoxidase were obtained from commercial suppliers. The proteins were dissolved in 10 mM phosphate buffer, pH 6.5. The concentrations of ⁇ -galactosidase and human glyoxylase were 0.05 and 0.15 mg/ml, respectively. For studies of intrinsic protein fluorescence the excitation wavelength was 295 nm. The emission spectra of two proteins in the presence and absence of silver islands were examined (FIGS. 11A and 11B). The proteins ⁇ -galactosidase and human glyoxylase were selected for their modest and low quantum yields.
- ⁇ -galactosidase has a quantum yield approximately equal to that of N-acetyl-L-tryptophamide (NATA) (D'Auria et al. (2001) J. Biochem. , in press) which is reported to be 0.13 (Demchenko, A. P. (1981). Ultraviolet Spectroscopy of Proteins, Springer-Verlag, New York.).
- the quantum yield of human glyoxylase was found to be about 10-fold less, and thus near 0.013. For the higher quantum yield ⁇ -galactosidase there was no significant effect of the silver islands on the emission spectra. For the lower quantum yield human glyoxylase are observed both a blue shift and an increase in emission intensity.
- ⁇ -galactosidase is a tetrameric protein, 480,000 molecular weight, which contains 26 tryptophan residues in each 120,000 dalton subunit (Jacobson et al. (1994) Nature 369, 761-766).
- Human glyoxylase is a 66,000 dalton monomer which contains two tryptophan residues (D'Auria, S., unpublished results).
- the spectra changes in FIG. 11B are due to increased emission from a highly quenched tryptophan residue in glyoxyalase which is shielded from the solvent.
- Adenine, thymine and calf thymus DNA were obtained from commercial suppliers.
- Poly T and poly C, each 15 bases long, were obtained from the Biopolymer Core facility at the University of Maryland, Baltimore School of Medicine.
- Emission spectra of the bases adenine and thymine are shown in FIGS. 12A and 12B, showing increased emission in the presence of the silver islands. Similar results were obtained for the single stranded nucleotides poly T and poly C (FIGS. 13A and 13B).
- the long wavelength emission maxima of poly C is in agreement with that reported previously (Plessow et al. (2000) J. Phys. Chem. B 104, 3695-3704).
- Intensity decays were measured through a combination 344 nm interference filter plus a WG 335 long pass filter, which provided transmission from about 330 to 355 nm. Emission spectra and lifetimes were measured with vertically polarized excitation and horizontally polarized emission. This optical configuration reduced scattered light of the excitation wavelength without significant distortion of the spectra or lifetimes.
- FIG. 15B One explanation of the increased intensity seen in FIG. 15B could be a decrease in the non-radiative decay rate k nr , which would result in a longer lifetime. Another reason for the increased emission could be an amplified incident light field. This effect would result in increased intensity, but is the lifetime would be unchanged.
- Frequency-domain intensity decays are shown in FIGS. 16A and 16B. These measurements were used to reconstruct the more intuitive time-domain decays (FIG. 17). The decays are multi-exponential in the absence or presence of metal islands (Table 1). The intensity decays were strongly heterogeneous or multi-exponential, which can be seen from the range of decay time from 60 ps to 4.56 ns.
- RET Resonance energy transfer
- Silver islands result in an increase in the acceptor emission near 590 nm. While this increase may appear modest, it is substantial for a mixture of fluorophores in which the acceptors are present at a concentration of 0.2 mM resulting in significant direct excitation of the acceptor.
- Calf thymus DNA was obtained from commercial suppliers and dissolved in 50 mM tris buffer, pH 7 to a concentration of 2 mM in base pairs using 13,300 M ⁇ 1 cm ⁇ 1 per base pair.
- DAPI and propidium iodide (PI) were obtained commercially.
- the DAPI and PI concentrations were 1.5 ⁇ 10 ⁇ 5 M and 1.5 ⁇ 10 ⁇ 4 M, respectively. These concentrations result in 133 base pairs per DAPI molecule and 13 base pairs per PI molecule.
- Emission spectra were obtained using a SLM 8000 spectrofluorometer using 360 nm excitation. Intensity decays were measured in the frequency-domain using instrumentation described previously (Laczko et al. (1990) Rev. Sci. Instrum. 61, 2331-2337; Lakowicz et al. (1994) Biophys. J. 46, 463-477).
- the excitation wavelength of 360 nm was obtained from the frequency-doubled output of a 3.80 MHz cavity dumped Pyridine 2 dye laser with a 10 ps or less pulse width.
- Silver particles were obtained by chemical reduction of silver onto quartz slides as above. If the mass thickness of the deposition silver is kept near 40 ⁇ the silver particles have sub-wavelengths dimensions and display the characteristics of surface plasmon absorption (FIG. 1). From studies of the absorption spectra of dyes between two such silver island films the sample thickness was found to be near 1 to 1.5 ⁇ m.
- DAPI donor decay was examined when the donor and acceptor-labeled DNA is in a 0.5 mm cuvette, between plain quartz plates, and between silver island films (Table 2).
- RhB, Eosin sodium salt, rose bengal and coumarin 152 were obtained from commercial suppliers.
- the experimental sample geometry is shown in FIG. 25.
- Two-photon excitation of RhB, eosin and rose bengal was accomplished with the 852 nm output of a Tsunami mode-locked Ti:Sapphire laser, 80 MHz repetition rate, 90 fs pulse, about 0.5 W average power.
- the multi-photon excitation wavelength was near 800 nm.
- the excitation was focused on the sample with a 15 cm radius concave mirror.
- the solution was placed between two high quality quartz plates, ⁇ /4 flatness. The plates were half uncoated and half coated with silver islands as described above.
- the thickness of the samples between the plates was about 1 ⁇ m.
- This sandwich sample was mounted on a x-y positioner.
- the focused spot of the laser was about 4 mm in length and 30 ⁇ m in diameter.
- the x-y positioner was used to move the sample so the laser illuminated regions with or without silver islands. This position change was accomplished without any change in the experimental geometry.
- Scattered excitation was eliminated with a combination of a heat filter and BG-38 glass filter for the emission spectra and a BG-38 and a 580 nm interference filter for time-resolved measurements.
- RhB The emission spectra of RhB between silver island films with two-photon excitation at 852 nm was examined (FIG. 26A).
- the emission intensity for RhB between the metal particles (indicated as—in FIG. 26A) was increased about 4-fold relative to RhB between uncoated quartz plates (indicated as - - - in FIG. 26A).
- the sample was first exposed to the focused 852 nm light, white light from the illuminated region was visibly detected. This “spark” decayed in less than one second, but some white light background remained. This white light was also seen from the silver islands alone without RhB (indicated as . . . in FIG. 26A).
- RhB RhB signal remained stable following the initial white light transient. RhB was also examined with one-photon excitation of 490 nm (FIG. 26, bottom). In this case there was almost no effect of the silver islands as compared to the uncoated quartz plates.
- RhB with two-photon excitation in the presence of silver islands was examined, but with the plates rotated so that the islands were on the outer surface not in contact with RhB (FIG. 27). In this case no difference between the silvered and unsilvered plates were found. The white continuum emission was still observed from the silver islands. This result demonstrated that the enhanced emission of RhB seen by FIG. 26 is due to two-photon excitation of RhB, and not due to second harmonic generation by the metal particles which in turn excites RhB.
- the results in FIG. 26 can be understood by considering the nature of our layered sample (see FIG. 1).
- the fluorophore is uniformly distributed in the 1 ⁇ thick sample.
- the region affected by the metal islands is expected to extend about 250 ⁇ in the solution. Recalling that there were two silver island surfaces, we estimated that only about 5% of the solution is within the active area. In fact, even this percentage is probably too high because the fluorophores within 50 ⁇ of the metal surface are typically quenched.
- the 4-fold enhancement for RhB (FIG. 26, top) suggests an 80-fold enhancement of two-photon excitation due to the metal particles.
- the small fraction of fluorophores near the metal particles explains the absence of a significant effect with one-photon (FIG. 26, bottom) because the majority of the emission occurs from RhB molecules distant from the silver islands.
- RhB lifetime with 852 nm excitation is the result of localized two-photon excitation of RhB molecules near the metal particles.
- the reduced RhB lifetime also demonstrated that the excitation is not due to second harmonic generation by the metal islands.
- the lifetime of RhB resulting from excitation by the harmonic would be the same as that found in the bulk solution.
- two-photon excitation there is essentially no emission from eosin or rose bengal under conditions where there is substantial emission from the fluorophores between the silver islands. This result suggested selective and localized two-photon excitation near metal particles.
- FIG. 33 is an illustration of how fluorophores on metal colloids can be selectively detected by multi-photon excitation in the presence of free fluorophore. Only the fluorophores within about 50 to about 2000 ⁇ , preferably from about 50 ⁇ to about 200 ⁇ , of a metal particle will have increased fluorescence when exposed to an amount of exciting radiation. The free fluorophores will not fluoresce at detectable levels.
- FIG. 34 is an illustration of localized multi-photon excitation of intracellular autofluorescence by metal colloids.
- a metal particle preferably a noble metal
- the metal particle is attached to an antibody that binds to a desired target.
- the metal particle is positioned near the target at a distance sufficient to increase the fluorescence of the target, typically about 50 to about 2000 ⁇ , preferably from about 50 ⁇ to about 200 ⁇ , in response to an exciting amount of fluorescence, preferably multi-photonic excitation.
- the antibody can be from any host animal capable of producing antibodies. Exemplary host animals include mammals, preferably rabbits, goats, horses, and humans.
- the antibody can also be conjugated with an extrinsic fluorophore.
- FIG. 35 depicts a schematic for an immunoassay assay.
- a capture antibody is covalently bound to the surface near the metal particles.
- the presence of the analyte (An) results in surface binding of a second antibody which is labeled with a non-fluorescent chromophore.
- exemplary non-fluorescent or weakly fluorescent chromophores fluorophore include, but are not limited to, rose bengal, eosin, malachite green, and organic molecules used as dyes or stains in optical microscopy.
- Suitable organic molecules used as dyes or stains in optical microscopy are well known in the art and include, but are not limited to, acid fuchsin, alcian blue, alizarin red, congo red, crystal violet, eosin, evans blue, light green SF, luxol fast blue, methyl green, neutral red, nigrosin, oil red o, orange g, picric acid, pyronin y, safranine o, sirius red, sudan black b, and toluidine blue o.
- the previously non-fluorescent species Upon binding to the antigen, the previously non-fluorescent species emits in response to an amount of exciting radiation due to the increased radiative rate.
- the unbound species more distant from the metal site will not interfere with the fluorescent signal because they do not fluoresce.
- the non-fluorescent species becomes a “molecular beacon” emitting only when close to the metal particles.
- antibodies or antibody fragments from any host capable of producing antibodies can be used.
- Exemplary hosts include mammals such as primates, goats, horses, rabbits, and rodents. Additionally, recombinant or chimeric antibodies can also be used.
- This assay can be used to detect the presence of an analyte in biologic fluids including, but not limited to, saliva, urine, mucus, blood, plasma, and lymphatic fluid.
- Exemplary analytes include steroids, small molecules, proteins, peptides, bacteria, and fungi.
- FIG. 36 depicts an assay of the present invention which uses electrical potential to gate the fluorescence on and off.
- a fluorophore is positioned at the end of a flexible polymer chain which is attached to a surface coated with metal particles
- the entire chain and fluorophore are negatively charged.
- the voltage or the metal is positive, the fluorophore is in the quenched zone.
- the voltage is negative, the fluorophore is displaced into the enhancement zone.
- the fluorophore is moved in and out of the shorter range quenching zone of the metal.
- the electric potential can be generated using known techniques.
- Suitable sources of electric potential include devices capable of producing electricity including, but not limited to, batteries, fuel cells, and transformers.
- a method to access array sensors using electric potential is provided using methods known for linking DNA or proteins in desired patterns on surfaces.
- biomolecules can be linked to surfaces using adhesives, polymers, lysine, or biotin-avidin.
- Another embodiment of the present invention discloses an immunoassay in wherein a first antibody is labeled with a donor molecule and a second antibody is labeled with an acceptor molecule (FIG. 37).
- the labeled antibodies will bind to their respective antigens to form a complex.
- the complex is near a metal particle, the resonance energy transfer from donor to acceptor is enhanced such that the emission from the acceptor is detectable.
- the complexes can be positioned near a silver island surface using electrical potential or other attractive forces. The metal-induced increased in the transfer rate results in transfer over larger distances, and the antigen is detectable by an increase in the transfer efficiency.
- FIG. 38 depicts another embodiment of the present invention, an apparatus for surface plasmon excitation.
- the emission increases at the critical angle for the fluorescence.
- the emission is sharply distributed at the plasmon angle for the emission wavelength.
- a typical metallic surface for this purpose would be a continuous, semi-transparent silver coating. This coating may be further modified by binding of metallic colloids or particles to provide both enhanced and directional emission.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
- This application claims benefit of priority to U.S. provisional application No. 60/268,326 entitled “RADIATIVE DECAY ENGINEERING” filed on Feb. 14, 2001.
- [0002] The work leading to this invention was supported in part by the U.S. Government under grant number RR-08119 awarded by the NIH National Center for Research Resources. Therefore, the U.S. Government may have certain rights in this invention.
- 1. Field of the Invention
- The present invention is directed to compositions and methods for increasing, and detecting the fluorescence of a molecule, in particular, compositions and methods for increasing the intrinsic fluorescence of a biomolecule. This invention also is directed to methods and compositions for the detection of biomolecules by increasing and detecting the fluorescence of biomolecules.
- 2. Description of Related Art
- The use of fluorescence technology has greatly enhanced the ability to detect specific molecules leading to rapid advancements in diagnostics. For example, fluorescence detection is widely used in medical testing and DNA analysis because of the high degree of sensitivity obtained using fluorescent techniques. Small numbers of molecules can be detected using fluorescence technology. Typically, extrinsic fluorophores are added covalently or non-covalently to allow molecules that do not ordinarily fluoresce or do not fluoresce at previously commercially useful levels to be detected. Biomolecules such as DNA ordinarily do not fluoresce at detectable levels, and extrinsic fluorophores are added to DNA to facilitate the detection of DNA on gels (Benson et al. (1993) Nucleic Acids Res. 21, 5720-5726; Benson et al. (1995) Ananl. Biochem. 231, 247-255), in DNA sequencing (Smith et al. (1986) Nature 321, 674-679; Prober et al. (1987) Science 238, 336-343; Li et al. (1999) Bioconjugate Chem. 10, 241-245), in fluorescence in-situ hybridization (Denijn et al. (1992) APMIS 100, 669-681; Wiegant et la. (2000) Genome Res. 10, 861-865), and for reading of DNA arrays for gene expression (Lipshutz et al. (1999) Nat. Genet. SuppL. 1, 20-24; Ferea et al. (1999) Curr. Opin. Genet. Dev. 9, 715-722). Extrinsic fluorophores are used with DNA because DNA absorbs in the UV region near 260 nm. The short absorption wavelength is now less of an obstacle because UV solid state lasers have become available. Nonetheless, the intrinsic fluorescence from DNA is of little practical usefulness because of the low quantum yields of 10−4 to 10−5 (Vigny et al. (1974) Photochem. Photobiol. 20, 345-349; Morgan et al. (1980) Photochem. Photobiol. 31, 101-113). Because the intrinsic emission from DNA, nucleotides and nucleic acid bases is very weak (Kneipp et al. (1999) Curr. Science 77, 915-924; Nie et al. (1997) Science 275, 1102-1106; Michaels et al. (1999) J. Am. Chem. Soc. 121, 9932-9939), it is difficult to observe the intrinsic fluorescence even with modem instrumentation (Gersten et al. (1985) Surface Science 158, 165-189; Lakowicz (2001) Anal. Biochem. 298, 1-24).
- Some of the fluorescence techniques used to detect the presence of molecules include Resonance Energy Transfer (RET), immunofluorescent assays, and fluorescence in situ hybridization. Detection of the molecule of interest is generally limited by the properties of the fluorophore used. In some cases, labeling a biomolecule with an extrinsic fluorophore can alter the biological activity of the biomolecule potentially creating experimental artifacts. Problems with current fluorescent techniques stem in part from the low fluorescent intensities of commonly used fluorophores. Additionally, background fluorescence can be significant when using low wavelength excitation radiation required by some fluorophores or when large quantities of fluorophore are required.
- DNA sequencing techniques using fluorescent dyes as markers have their maximum emission spectra in the visible range, the DNA is subject to irradiation in the visible spectra, and visible spectra detectors and light sources are used. Generally photomultipliers tubes are used for detection. As a result, these DNA sequencing techniques have several disadvantages including high costs resulting from the high cost of the lasers used to excite the fluorescent markers which typically emit in the visible region of light spectrum and the high noise to signal ratio due to the background interferences by biomolecules.
- Thus, there is a need for compositions and methods for increasing the fluorescence intensity of biomolecules.
- There is also a need for compositions and methods for increasing the intrinsic fluorescence of biomolecules.
- Another need exists for compositions and methods for manipulating the fluorescence emission intensity of a biomolecule in response to an amount of exciting radiation.
- Yet another need exists for methods and compositions for manipulating the radiative decay rate of biomolecules.
- One aspect of the present invention is directed to a biomolecule in combination with a metal particle, wherein the metal particle and the biomolecule are positioned at a distance apart sufficient to enhance intrinsic emission of electromagnetic radiation from the biomolecule in response to an amount of exciting electromagentic radiation. Exemplary biomolecules include, but are not limited to, purines, pyrimidines, nucleic acids, oligonucleotides, peptide nucleic acids, RNA, DNA, amino acids, proteins, peptides, vitamins, lipids, carbohydrates, steroids and antibodies. Exemplary metals include, but are not limited to, rhenium, ruthenium, rhodium, palladium, silver, copper, osmium, iridium, platinum, and gold. The present invention is predicated on the surprising discovery that the fluorescence intensity of a biomolecule can be manipulated by varying the distance between the biomolecule and a metal particle. It will be appreciated by one of ordinary skill in the art that the scope of the present invention includes increasing the intrinsic fluorescence of a biomolecule as well as the fluorescence of a biomolecule labeled with extrinsic probes. The extrinsic fluorescence of a biomolecule includes but is not limited to the fluorescence of a fluorophore conjugated to the biomolecule. Such extrinsic fluorophores can be covalently or non-covalently attached to the biomolecule. Other aspects of the present invention describe novel compositions and methods for the detection of biomolecules. The present invention overcomes the problems associated with background fluorescence because the signal to noise ratio is increased when the fluorescence intensity of the biomolecule is increased. Additionally, expensive lasers are not required, thereby reducing costs. Extrinsic fluorophores may not be required making fluorescence assays of biomolecules quicker and less expensive.
- Another aspect of the present invention provides a method for increasing the intrinsic fluorescence of a biomolecule including the step of positioning a metal particle and the biomolecule at a distance apart sufficient to increase the electromagnetic emission from the biomolecule in response to an amount of exciting radiation. It will be appreciated that the present invention includes positioning of a biomolecule adjacent to a metal particle or positioning a metal particle adjacent to biomolecule in any of the disclosed embodiments.
- Still another aspect of the present invention provides a method for detecting a biomolecule including the steps of positioning a metal particle and a biomolecule at a distance apart sufficient to manipulate the electromagnetic emission from the biomolecule, exposing the biomolecule to an amount of exciting radiation, and detecting the electromagnetic emission from the biomolecule.
- Yet another aspect provides a method for manipulating fluorescence intensity of a biomolecule including the steps of increasing the rate of radiative decay of the biomolecule by positioning the biomolecule adjacent to a metal particle, and exposing the biomolecule to an amount of exciting radiation. By increasing the rate of radiative decay, the fluorescence intensity of the biomolecule can be increased.
- Another aspect of the present invention discloses a method for detecting the presence of a nucleic acid sequence in a sample including the steps of providing a sample, adding a nucleic sequence linked to a metal particle, exposing the sample to an amount of exciting radiation, detecting the fluorescence, and determining the presence of a nucleic acid sequence based on the detection of the fluorescence.
- Still another aspect provides a method for increasing the fluorescence intensity of a fluorescently labeled biomolecule including the steps of labeling a biomolecule with a fluorophore, positioning the labeled biomolecule next to a metallic particle such that in response to an amount of exciting radiation, the fluorophore emits radiation.
- Yet another aspect provides a method for increasing fluorescence energy transfer on a fluorescently labeled biomolecule including the steps of labeling a first biomolecule with a donor fluorophore and labeling a second biomolecule with an acceptor fluorophore, positioning both the first labeled biomolecule and the second labeled biomolecule adjacent to a metal particle such that in response to an amount of exciting radiation, the donor fluorophore transfers energy to the acceptor fluorophore causing the acceptor fluorophore to emit electromagnetic radiation.
- Another aspect provides a method for increasing fluorescence energy transfer on a fluorescently labeled biomolecule including the steps of labeling a biomolecule with a donor fluorophore and an acceptor fluorophore, positioning the labeled adjacent to a metal particle such that in response to an amount of exciting radiation, the donor fluorophore transfers energy to the acceptor fluorophore causing the acceptor fluorophore to emit electromagnetic radiation.
- Another aspect of the present invention provides a method for increasing the fluorescent intensity of a fluorophore including the steps of positioning a fluorophore adjacent to a metal particle, and exciting the fluorophore with a plurality of photons (this process is referred to as multi-photon excitation).
- Another aspect of the present invention provides a method for increasing the fluorescent intensity of a biomolecule including the steps of positioning a biomolecule adjacent to a metal particle, and exciting the biomolecule with a plurality of photons.
- Yet another aspect of the present invention provides a method for selectively enhancing a region of electromagnetic emission of a sample including the steps of directing a metal particle to a region of interest in the sample, and providing an amount of exciting radiation in the sample.
- Another aspect of the invention provides a method for selectively enhancing the region of electromagnetic emission of a sample including the steps of directing a metal particle to a region of interest in the sample, contacting the sample with a fluorophore, and exposing the sample to an amount of exciting radiation.
- For a better understanding of the present invention, together with other and further objects thereof, reference is made to the following description, taken in conjunction with the accompanying drawings, and its scope will be pointed out in the appending claims.
- FIGS. 1A and 1B depict silver metal islands on a quartz surface and its absorption spectrum, respectively.
- FIGS. 2A-C are absorption spectra of rose bengal in a cuvette, between quartz plates, and between quartz slides with silver islands respectively.
- FIGS. 3A, 3B are emission spectra of rhodamine B and rose bengal between silver island films.
- FIGS. 4A-4C are a graphs showing frequency-domain intensity decays of rhodamine B under various conditions.
- FIGS. 5A-5C are graphs showing frequency-domain intensity decays of rose bengal under various conditions.
- FIGS. 6A-6B are reconstructed time-domain intensity decays of rhodamine B and rose bengal.
- FIGS. 7A-7D are emission spectra of Erb, BF, [Ru(bpy)3]2+, and [Ru(phen)2dppz]2+ between silver island films (S) and between uncoated quartz plates (Q).
- FIG. 8 is a graphical depiction of the enhancement of the emission of fluorophores having different quantum yields when placed between silver island films.
- FIG. 9 is a graphical depiction of the fluorescence intensity of [Ru(phen) 2dppz]2+ between silver island films (Is) compared to the fluorescence intensity between quartz plates (IQ) in solutions of DMF and water. [Ru{phen}2dppx]2+ decreases in fluorescence intensity in the presence of water (inset). FIG. 9 shows that silver island particles have a greater enhancement (IS/IQ) on [Ru(phen)2dppz]2+ in solutions having more water than DMF. Thus, silver island films have a greater enhancement of fluorescence intensity on weak or quenched fluorophores than on strong or non-quenched fluorophores.
- FIGS. 10A and 10B are emission spectra of solvent-sensitive fluorophores between silver island films (S) and between uncoated quartz plates (Q).
- FIGS. 11A and 11B are emission spectra of β-galactosidase and human glyoxalase between silver island films (S) and between uncoated quartz plates (Q).
- FIGS. 12A and 12B are emission spectra of nucleic acid bases between silver island films (S) and between uncoated quartz plates (Q).
- FIGS. 13A and 13B are emission spectra of single stranded nucleic acids between silver island films (S) and between uncoated quartz plates (Q).
- FIGS. 14A and 14B are absorption spectra of calf thymus DNA in a cuvette ( 14A) and between silver island films or uncoated quartz plates (14B).
- FIGS. 15A and 15B are the emission spectra of DNA in a cuvette ( 15A) and between silver island films or uncoated quartz plates (15B).
- FIGS. 16A and 16B are frequency-domain intensity decays of calf thymus DNA in a cuvette ( 16A) and between silver island films (16B).
- FIG. 17 is time dependent intensity decays of calf thymus DNA between silver island films and in a cuvette.
- FIG. 18 is emission spectra of R6G as donor and SR101 as acceptor between uncoated quartz plates and between silver island films.
- FIG. 19 is emission spectra of DNA labeled with DAPI and acridine orange between silver island films and between uncoated quartz plates.
- FIG. 20 is emission spectra of DNA labeled with DAPI alone; with propidium iodide (PI) alone; or with DAPI and PI between uncoated quartz plates.
- FIG. 21 is emission spectra of DAPI-labeled DNA and PI-labeled DNA between silver island films and between uncoated quartz plates.
- FIG. 22 is emission spectra of DNA labeled with both DAPI and PI between silver island films and between uncoated quartz plates.
- FIGS. 23A-23C are frequency-domain intensity decays of the DAPI donor decay for calf thymus DNA labeled with both DAPI and PI in a cuvette (23A), between uncoated quartz plates (23B), and between silver islands (23C). The frequency-domain intensity decay of DAPI alone is also shown.
- FIGS. 24A-24C are the frequency-domain intensity decays of DAPI in calf thymus DNA labeled with both DAPI and PI in a cuvette (24A), between uncoated quartz plates (24B), and between silver islands (24C).
- FIG. 25 is an exemplary geometry for detecting fluorophores between silver island films.
- FIGS. 26A and 26B are emission spectra of rhodamine B between silver island films and uncoated quartz plates using one-photon excitation and two photon excitation.
- FIG. 27 emission spectra of rhodamine B with two photon excitation between uncoated quartz plates and between quartz plates with silver islands on the outer surface of the quartz plates.
- FIGS. 28A and 28B are frequency-domain intensity decays of rhodamine B with one photon excitation between uncoated quartz plates ( 28A) and between silver island films (28B).
- FIGS. 29A and 29B are frequency-domain intensity decays of rhodamine B with two photon excitation between uncoated quartz plates ( 29A) and between silver island films (29B).
- FIGS. 30A and 30B are graphs depicting the photostability of rhodamine B between uncoated quartz plates (Q) and between silver island films (S).
- FIGS. 31A and 31B are emission spectra of eosin ( 31A) and rose bengal (31B) between uncoated quartz plates (Q) and between silver island films (S) using two photon excitation.
- FIGS. 32A and 32B are emission spectra of coumarin ( 32A) between uncoated quartz plates (Q) and between silver island films (S) and ANS (32B) in a cuvette (C), between uncoated quartz plates (Q), and between silver island films (S).
- FIG. 33 is a depiction of selective multi-photon excitation of fluorophores on metal colloids in the presence of free fluorophore.
- FIG. 34 is a depiction of localized multi-photon excitation of intracellular autofluorescence by metal colloids.
- FIG. 35 is an exemplary embodiment of a sandwich immunoassay in conjunction with a silver island coated surface.
- FIGS. 36A-C are an exemplary embodiment of voltage-activated fluorescence assays.
- FIGS. 37A-C are an exemplary embodiment of an energy transfer immunoassay using donor and acceptor-labeled antibodies.
- FIG. 38A is an exemplary apparatus for surface plasmon excitation and FIG. 38B is a graph of the angular distribution of the fluorescence from rhodamine 6G.
-
Abbreviations: AO acridine orange BF Basic Fucsin bpy 2,2′-bipyridine CT calf thymus DAPI 4′,6-diamidino-2-phenylindole dppz dipyrido[3,2-a:2′,3′-c]phenazine DMF Dimethylformamide ErB Erythrosin B phen 9,10-phenanthroline prodan 6-Propionyl-2-(dimethylamino) naphthalene Py2 Pyridine 2 R6G Rhodamine 6G RhB Rhodamine B RB Rose Bengal RET Resonance energy transfer SERS Surface-enhanced Raman scattering SIF Silver island films SR101 Sulforhodamine 101 A acceptor D donor DAPI 4′,6-diamidino-2-phenylindole FD frequency-domain PI propidium iodide RET resonance energy transfer - Definitions
- The term “fluorophore” means any substance that emits electromagnetic energy such as light at a certain wavelength (emission wavelength) when the substance is illuminated by radiation of a different wavelength (excitation wavelength). Extrinsic fluorophores refers to fluorophores bound to another substance. Intrinsic fluorophores refers to substances that are fluorophores themselves. Exemplary fluorophores include but are not limited to those listed in the Molecular Probes Catalogue which is incorporated by reference herein. Representative fluorophores include but are not limited to Alexa Fluor® 350, Dansyl Chloride (DNS-Cl), 5-(iodoacetamida)fluoroscein (5-IAF); fluoroscein 5-isothiocyanate (FITC), tetramethylrhodamine 5- (and 6-)isothiocyanate (TRITC), 6-acryloyl-2-dimethylaminonaphthalene (acrylodan), 7-nitrobenzo-2-oxa-1,3,-diazol-4-yl chloride (NBD-Cl), ethidium bromide, Lucifer Yellow, 5-carboxyrhodamine 6G hydrochloride, Lissamine rhodamine B sulfonyl chloride, Texas Red™ sulfonyl chloride, BODIPY™, naphthalamine sulfonic acids including but not limited to 1-anilinonaphthalene-8-sulfonic acid (ANS) and 6-(p-toluidinyl)naphthalene-2-sulfonic acid (TNS), Anthroyl fatty acid, DPH, Parinaric acid, TMA-DPH, Fluorenyl fatty acid, Fluorescein-phosphatidylethanolamine, Texas red-phosphatidylethanolamine, Pyrenyl-phophatidylcholine, Fluorenyl-phosphotidylcholine, Merocyanine 540,1-(3-sulfonatopropyl)-4-[β-[2[(di-n-butylamino)-6naphthyl]vinyl]pyridinium betaine (Naphtyl Styryl), 3,3'dipropylthiadicarbocyanine (diS-C 3-(5)), 4-(p-dipentyl aminostyryl)-l-methylpyridinium (di-5-ASP), Cy-3 lodo Acetamide, Cy-5-N-Hydroxysuccinimide, Cy-7-Isothiocyanate, rhodamine 800, IR-125, Thiazole Orange, Azure B, Nile Blue, Al Phthalocyanine, Oxaxine 1, 4′, 6-diamidino-2-phenylindole (DAPI), Hoechst 33342, TOTO, Acridine Orange, Ethidium Homodimer, N(ethoxycarbonylmethyl)-6-methoxyquinolinium (MQAE), Fura-2, Calcium Green, Carboxy SNARF-6, BAPTA, coumarin, phytofluors, Coronene, and metal-ligand complexes. Representative intrinsic fluorophores include but are not limited to organic compounds having aromatic ring structures including but not limited to NADH, FAD, tyrosine, tryptophan, purines, pyrimidines, lipids, fatty acids, nucleic acids, nucleotides, nucleosides, amino acids, proteins, peptides, DNA, RNA, sugars, and vitamins. Additional suitable fluorophores include enzyme-cofactors; lanthanide, green fluorescent protein, yellow fluorescent protein, red fluorescent protein, or mutants and derivates thereof.
- The term “biomolecule” means any carbon based molecule occurring in nature or a derivative of such a molecule. The biomolecule can be in active or inactive form. “Active form” means the biomolecule is in a form that can perform a biological function. “Inactive form” means the biomolecule must be processed either naturally or synthetically before the biomolecule can perform a biological function. Exemplary biomolecules include nucleic acids, aromatic carbon ring structures, NADH, FAD, amino acids, carbohydrates, steroids, flavins, proteins, DNA, RNA, oligonucleotides, peptide nucleic acids, fatty acids, sugar groups such as glucose etc., vitamins, cofactors, purines, pyrimidines, formycin, lipids, phytochrome, phytofluor, and phycobiliproptein.
- The term “amount of exciting radiation” means an amount of radiation that causes a molecule to emit radiation.
- Exemplary Embodiments
- One embodiment of the present invention is directed to a biomolecule in combination with a metal particle, wherein said metal particle and the biomolecule are positioned at a distance apart sufficient to adjust, preferably enhance, intrinsic emission of electromagnetic radiation from the biomolecule in response to an amount of exciting electromagnetic radiation. Exemplary biomolecules include but are not limited to purines, pyrimidines, nucleic acids, oligonucleotides, peptide nucleic acids, RNA, DNA, amino acids, flavins, proteins, peptides, vitamins, lipids, antibodies, and aromatic carbon ring structures. Preferred biomolecules and fluorophores of the present invention have quantum yields of less than about 0.8, more preferably of less than about 0.5, and most preferably of less than about 0.2. Exemplary metals include copper and noble metals such as rhenium, ruthenium, rhodium, palladium, silver, osmium, iridium, platinum, and gold. Similarly, another embodiment provides a composition of matter including a biomolecule in combination with a metal surface wherein said metal surface and the biomolecule are positioned at a distance apart sufficient to adjust, preferably enhance, intrinsic emission of electromagnetic radiation from the biomolecule in response to an amount of exciting electromagnetic radiation. Still, another embodiment provides that the metal surface can be a periodic metal surface.
- The present invention is predicated on the surprising discovery that the fluorescence intensity of a biomolecule can be manipulated by varying the distance between the biomolecule and a metal particle. Indeed, it has been discovered that the intrinsic fluorescence of a biomolecule can be increased by at least about 80 fold to about 140 fold when the biomolecule is positioned adjacent to a metal particle. Preferably the metal particle and biomolecule are separated by a distance of about 50 Å to about 2000 Å, most preferably from about 50 Å to about 200 Å. In another embodiment, the metal particle is sub-wavelength in size, typically in the range of about 50 Å to about 300 Å. The metal particles can be spheroid, ellipsoid, or of any other geometry. The metal particles can be suspended in a colloid or combination of colloids, alloys, or combinations of more than one metal. The metal particles can be placed on surfaces as thin films, or deposited on surfaces to form small islands. The surfaces can be metallic or non-metallic. Additionally, the metal particles can be coated with polymers, gels, adhesives, oxides, or biologic material. Exemplary coatings include substances that increase the binding of the metal particle to surfaces or other molecules. In one embodiment, the metal particles can be modified on its surface to facilitate binding to non-metallic molecules and biomolecules. In an exemplary embodiment, metal particles, preferably noble metals, most preferably silver, are chemically reduced on a surface. Chemical reduction can be accomplished using known techniques. Exemplary surfaces include but are not limited to glass or quartz.
- In another embodiment, the biomolecule and the metal particle can be attached to each other via an intermediate of a length sufficient to have a desired effect on the intrinsic fluorescence of the biomolecule. The attachment can be covalent or non-covalent. Additionally, the metal and biomolecule can be stably linked or can be linked such that the two can become separated as a result of a chemical reaction, enzymatic reaction, or photoreaction. For example, a biomolecule linked to a metal particle can be internalized within a cell, cellular organelle, or other compartment. Once internalized, the linked biomolecule can be subjected to enzymatic or chemical reaction resulting in the complete separation of the metal particle from the biomolecule. Exemplary enzymatic reactions include, but are not limited to, non-specific esterase reactions, and exemplary chemical reactions include but are not limited to hydrolysis, oxidation, or substitution. Once separated, the biomolecule can become undetectable or less detectable because its intrinsic fluorescence is no longer amplified by the metal particle. If the intrinsic fluorescence of the biomolecule is desired to be quenched, the biomolecule and the metal particle can be separated by a distance of about 0 to less than 50 Å. If the intrinsic fluorescence of the biomolecule is to be increased, the biomolecule and the metal particle can be separated by a distance of about 50 Å to about 2000 Å, more preferably from about 50 Å to about 200 Å. Thus, the fluorescence intensity of a biomolecule can be manipulated by varying the distance separating the metal particle from the biomolecule.
- It will be appreciated by one of ordinary skill in the art that the scope of the present invention includes increasing the extrinsic fluorescence of a biomolecule as well as the intrinsic fluorescence of the biomolecule. The extrinsic fluorescence of a biomolecule includes but is not limited to the fluorescence of a fluorophore conjugated to the biomolecule. Such conjugated fluorophores can be covalently or non-covalently attached to the biomolecule. An increase or decrease in fluorescence intensity in the present invention means an increase or decrease in intrinsic or extrinsic fluorescence intensity when the biomolecule or fluorophore is in combination with a metal particle compared to the intrinsic or extrinsic fluorescence intensity of the biomolecule or fluorophore in the absence of a metal particle.
- Another embodiment of the present invention provides a method for increasing the intrinsic fluorescence of a biomolecule including the step of positioning the biomolecule and a metal particle at a distance apart sufficient to increase the electromagnetic emission from the biomolecule in response to an amount of exciting radiation. It will be appreciated that the present invention includes positioning of a biomolecule adjacent to a metal particle or positioning a metal particle adjacent to the biomolecule in any of the disclosed embodiments. In an exemplary embodiment, the biomolecule and the metal particle are separated by a distance of about 50 Å to about 2000 Å, preferably from about 50 Å to about 200 Å, to increase the intrinsic fluorescence of the biomolecule or separated by a distance of less than about 50 Å if the intrinsic fluorescence is to be quenched. In other embodiments, the metal particles can be fixed on a surface, and the biomolecule positioned adjacent to such a surface. Such surfaces can form a part of cuvette or can be an insert capable of being placed within a cuvette.
- Positioning of the biomolecule or metal particle at a desired distance can be achieved by using a linker that physically links the two. Linkers can be one intervening atom or molecule, preferably carbon chains of at least one carbon atom. Other linkers include but are not limited to at least one amino acid. Additionally, other chemical linkers known in the art can be used. The linkers can be of any length, preferably of up to about 200 Å depending the desired effect on fluorescence. In other embodiments, the metal particle can be positioned adjacent to the biomolecule using electromagnetic forces, charged fields, gravity or other known methods. In one example, voltage can be regulated to manipulate the position of the metal particle, or linked biomolecule and metal particle. Alternatively, the biomolecule can be positioned using electromagnetic fields, electric currents, voltage, or gravity.
- Yet another embodiment of the present invention provides a method for detecting a biomolecule including the steps of positioning said biomolecule and a metal particle at a distance apart sufficient to manipulate the electromagnetic emission from the biomolecule, exposing the biomolecule to an amount of exciting radiation, and detecting the electromagnetic emission from the biomolecule. Monitoring, detecting, and quantifying fluorescence is known in the art. See for example Joseph R. Lakowicz. Principles in Fluorescence Spectroscopy, Plenum Publishers 1999 which is incorporated by reference herein in its entirety.
- Briefly, fluorescence can be detected using devices including, but not limited to, a spectrofluorometer having a light source and detector. Light sources can include arc lamps and lasers. Detectors can include photomultiplier tubes. Additionally, it is advantageous for the device to have a monochromator so that specific wavelengths of light may be used to excite a molecule or to detect emissions at a specific wavelength. When a sample containing a fluorophore is placed in the spectrofluorometer and exposed to an amount of exciting radiation, the fluorophore emits radiation that is detected by a photomultiplier tube. The fluorescence intensity of a biomolecule can be increased in response to an amount of exciting radiation when the distance between the metal particle and the biomolecule is from about 50 Å to about 2000 Å, preferably from about 50 Å to about 200 Å. Alternatively, the fluorescence intensity of the biomolecule can be reduced when the distance between the biomolecule and the metal particle is less than about 50 Å.
- Yet another embodiment provides a method for manipulating fluorescence intensity of a biomolecule including the steps of increasing the rate of radiative decay of the biomolecule by positioning the biomolecule adjacent to a metal particle, and exposing the biomolecule to an amount of exciting radiation. By increasing the rate of radiative decay, the fluorescence intensity of the biomolecule can be increased. It has been discovered that by manipulating the distance separating a biomolecule and a metal particle, the radiative decay of the biomolecule can also be manipulated.
- Another embodiment of the present invention discloses a method for detecting the presence of a nucleic acid sequence in a sample including the steps of providing a sample, adding a nucleic sequence linked to a metal particle, exposing the sample to an amount of exciting radiation, detecting the fluorescence, and determining the presence of the nucleic acid sequence based on the detection of the fluorescence. In one embodiment, the nucleic acid sequence linked to a metal particle is single stranded. In other embodiments, the nucleic acid sequence linked to the metal particle is double stranded. In a preferred embodiment, the nucleic acid sequence linked to a metal particle is less than two hundred base pairs in length, more preferably, less than 100 base pairs in length, most preferably less than 50 base pairs in length, even more preferably, about twenty or less nucleic acids in length. The nucleic acids can be deoxyribonucleic acids, ribonucleic acids, or chemically modified nucleic acids such as peptide nucleic acids and the like.
- Methods for the hybridization of nucleic acids are known in the art. See for example Nonradioactive In Situ Hybridization Application Manual at biochem.roche.com/prod_inf/manuals/insitu/insi_toc.htm incorporated by reference in its entirety. Historically, the detection of hybridized nucleic acid used labeled nucleic acid probes to hybridize to a nucleic acid sample. For example, in a Southern blot technique, a nucleic acid sample is separated in an agarose gel based on size and affixed to a membrane, denatured, and exposed to the labeled nucleic acid probe under hybridizing conditions. If the labeled nucleic acid probe forms a hybrid with the nucleic acid on the blot, the label is bound to the membrane. Probes used in Southern blots have been labeled with radioactivity, fluorescent dyes, digoxygenin, horseradish peroxidase, alkaline phosphatase and acridinium esters.
- The present invention discloses a novel method for the detection of nucleic acid sequences by increasing the intrinsic fluorescence of the nucleic acids. This increase is accomplished by linking the nucleic acid to a metal, preferably a noble metal. The present invention does not require the use of an extrinsic probe. Rather when the nucleic acid sequence linked to a metal particle is added to a sample, this sequence can hybridize to complementary nucleic acid sequences in the sample. In a preferred embodiment the nucleic acid sequence to be detected can be affixed to a solid support. Exemplary solid supports include films, membranes, columns, nitrocellulose, plastic, quartz, glass, or metal. The sample is irradiated with an amount of exciting radiation. Fluorescence detected in the sample or, for example, on the solid support would indicate that the nucleic acid linked to the metal particle has hybridized to a complementary nucleic acid sequence present in the sample. Therefore, the sample contains the nucleic acid sequence of interest. Nucleic acids not linked to a metal particle would not contribute significantly to fluorescence emission because the quantum yield of nucleic acids is too low. It will be appreciated that the nucleic hybridization detected by the present invention can occur in situ. Additionally, it will be appreciated that the detection of the nucleic acid can be based on increasing the fluorescence intensity of an extrinsic fluorophore attached to a nucleic acid by positioning the fluorophore adjacent to a metal particle. Increasing the intrinsic fluorescence of nucleic acids can be useful in DNA arrays or gene chips.
- In another embodiment, the present invention provides a method for identifying nucleic acids, the method including the steps of positioning a nucleic acid adjacent to a metal particle, irradiating the nucleic acid, detecting the fluorescence emission from the nucleic acid, and identifying the nucleic acid based on the fluorescence emission. The identification of nucleic acids using the intrinsic fluorescence of the nucleic acid eliminates the requirement for extrinsic probes. In one embodiment, the background fluorescence is not problematic because the intrinsic fluorescence can be increased by about 80 fold thereby reducing the noise to signal ratio. In another embodiment, the nucleic acid can be identified based on the emission spectra obtained from monitoring the fluorescence of the sample. Thus, the sequence of nucleic acids in a sample can be determined by sequentially removing a nucleic acid, positioning the nucleic acid adjacent to metal particle, irradiating the nucleic acid with an amount of exciting radiation, detecting the emitted radiation, and correlating the emitted radiation with the nucleic acid base. Methods for sequentially removing a single nucleic acid form a nucleic acid sequence such as an oligonucleotide are known in the art and include sequential digestion, hydrolysis, and chemical cleavage. The nucleic acids can be positioned adjacent to a metal particle by causing the stream of a fluid sample containing a nucleic acid to pass near a surface containing the metal particle. Such surfaces can be thin films or islands of metal that form part of a sample chamber. The irradiation of the nucleic acid can be timed to coincide with the positioning of the nucleic acid adjacent to the metal. The nucleic acids can be irradiated with one or more wavelengths. In a preferred embodiment, the nucleic acids are excited at wavelengths below 300 nm, preferably from 280 to about 295 nm. In another embodiment, the excitation wavelength is near 520 nm for multi-photon excitation.
- It will be appreciated by those of ordinary skill in the art, that the methods and compositions of the present invention can be used in polymerase chain reaction techniques. Polymerase chain reaction techniques are will known in the art. Nucleic acids coupled to metal particles, preferably noble metal particles, can be added to the polymerase chain reaction mixtures. The coupled nucleic acids can be incorporated into the growing oligonucleotide chain, and in response to an amount of exciting radiation, the fluorescence of the coupled nucleic acid will be detectable enabling the detection of the polymerase chain reaction product.
- Still another embodiment provides a method for increasing the fluorescence intensity of a fluorescently labeled biomolecule including the steps of labeling a biomolecule with a fluorophore, positioning the labeled biomolecule adjacent to a metallic particle such that in response to an amount of exciting radiation, the fluorophore emits radiation, preferably detectable amounts of radiation. In a preferred embodiment, the fluorophore has a quantum yield of less than 0.8, preferably less than 0.5, more preferably less than 0.2, and most preferably less than 0.1. In this embodiment, the fluorescence intensity of an extrinsic fluorophore can be used to detect the biomolecule.
- Yet another embodiment provides a method for increasing fluorescence energy transfer on a fluorescently labeled biomolecule including the steps of labeling a first biomolecule with a donor fluorophore and labeling a second biomolecule with an acceptor fluorophore, positioning the labeled biomolecules adjacent to a metal particle such that in response to an amount of exciting radiation, the donor fluorophore transfers energy to the acceptor fluorophore causing the acceptor fluorophore to emit electromagnetic radiation.
- Another embodiment provides a method for increasing fluorescence energy transfer on a fluorescently labeled biomolecule including the steps of labeling a biomolecule with a donor fluorophore and an acceptor fluorophore, positioning the labeled adjacent to a metal particle such that in response to an amount of exciting radiation, the donor fluorophore transfers energy to the acceptor fluorophore causing the acceptor fluorophore to emit electromagnetic radiation.
- Increases in energy transfer due to metallic particles can be used in immunoassays. Thus, in one embodiment, the compositions of the present invention can use fluorescence energy transfer to measure an affinity reaction, preferably an antibody-antigen reaction or a protein-carbohydrate interaction. Additionally, assay chambers coated with or containing metallic particles can be used to increase the efficiency or RET even between donor and acceptors to span distances over 100 Å apart. Metal enhanced energy transfer is also useful with DNA arrays or gene chips. In another embodiment, the compositions and methods of the present invention can utilize fluorescence energy transfer to measure DNA hybridization or the amount of double helical DNA. At present the arrays are read by measuring the amount of two fluorophores hybridized to the target DNA (Ferea et al. (1999) Curr. Opin. Genetics Dev., 9, 715-722; Lipshutz et al. (1999). Nature Gen. SuppL. 1, 20-24; Hacia et al. (1998) Molec.
Psychiatry 3, 483-492). Even though the two dyes are probably a good donor-acceptor pair, energy transfer does not normally occur. The use of DNA arrays on metallic surfaces provides a new type of DNA array analysis based on RET between donors and acceptors positioned at long distances. - Methods and procedures for producing biochips, gene chips. or microarrays are known in the art. For example, U.S. Pat. No. 6,174,683 discloses methods and compositions relating to “biochips' and the formation of “biochips” and is incorporated herein in its entirety. Nucleic acid probes are affixed to a microarray surface. In the present invention, the microarray surface is a metal surface, preferably a noble metal, most preferably a silver surface. The surface can be coated with metal islands as describe above. Generally, total RNA is prepared from a sample or samples to determine the pattern of gene expression. These samples can be different cell lines, tumor samples, normal vs. disease, control or drug-treated, etc. In most cases, a minimum of about 1 μg of polyA+RNA or about 5 μg of total RNA is required. However, as little as 0.2 μg of “good quality” polyA+RNA can be used. As a general rule, 1×10 6 tissue culture cells should yield 10-15 μg of total RNA.
- Using Reverse Transcriptase, the RNA is converted into cDNA. At this point the cDNA can be labeled directly by incorporation of fluorescently-tagged dNTPs. More commonly, the cDNA is prepared using an oligo-dT primer that incorporates a T7 RNA polymerase promoter. The cDNA is then used in a subsequent step to make fluorescently-tagged copy RNA, using T7 RNA polymerase. In general, at least about 5 μg of labeled cRNA or cDNA is required for hybridizing to each microarray. However, the probes can be reused. For example, one labeled probe can be used sequentially to hybridize to five separate arrays.
- The fluorescently-labeled probes are hybridized to the microarrays, much as radioactive probes are hybridized to conventional dot-blots. The fluorescence of the labeled probe will increase in response to an amount of exciting radiation when the probe hybridizes to a complementary sequence because it is positioned near the metal microarray surface, preferably from about 50 Å to about 2000 Å, more preferably from about 50 Å to about 200 Å, from the metal surface. In another embodiment, the probe can be labeled with a donor and an acceptor fluorophore. When the labeled probe hybridizes to its complement on the microarray surface, it is positioned near the metal microarray surface, preferably from about 50 Å to about 2000 Å, more preferably from about 50 Å to about 200 Å, from the metal surface. In this position, the fluorescence energy transfer from the donor to the acceptor molecule is increased in response to an amount of exciting radiation enabling detection of the labeled probe. Detection of the labeled probe on the microarray indicates that the probe has hybridized to a complementary sequence further indicating expression of the corresponding gene. In still another embodiment, the nucleic acid sequence affixed to the metal coated microarray surface can be labeled with a donor or acceptor molecule, and the nucleic acid probe can be labeled with acceptor or donor molecule respectively such that when the nucleic acid probe hybridizes with a labeled nucleic acid sequence on the microarray surface, the fluorescence energy transfer from the donor molecule to the acceptor molecule is increased in response to an amount of exciting radiation.
- After washing, the microarrays are analyzed using a fluorescent scanner: a cross between a typical flat-bed scanner and a confocal microscope. The data is an image of the fluorescent spots on the microarray. The image can be analyzed using software that identifies the spots and calculates the intensity of the fluorescence in each one. By comparing the intensities obtained with two different probes (e.g. control vs. drug-treated), one can determine how the expression of each gene in the array changes.
- In other embodiment, proteins can be arrayed on metal surfaces, preferably noble metal surfaces, most preferably silver coated surfaces. Generally, to array proteins on a surface, a GMS 417 Arrayer (Affymetrix, Santa Clara, Calif.) or other suitable device can be used. The arrayer picks up about a microliter of sample from four wells of a 96- or 384-well plate and deposits about 1 nanoliter of each sample at defined locations on a series of glass microscope slides. The arrayer can use a pin and ring system: the samples are picked up in small rings that each hold about 1 microliter and a solid pin (150 μm diameter) then punches repeatedly through the ring to deposit the proteins on the slides. To prevent evaporation of the nanodroplets, 40% glycerol is included in the protein samples. Nanoliter droplets of 40% glycerol remain hydrated, even when left exposed to the atmosphere overnight.
- To study protein function, it is necessary to immobilize the proteins in a way that preserves their folded conformations. In addition, it is preferred to minimize nonspecific binding of other proteins to the surface in subsequent steps. To accomplish these goals, chemically derivatized slides can be used. For most applications, slides that have been treated with an aldehyde-containing silane reagent are used. These slides can also be purchased from TeleChem International under the trade name SuperAldehyde Substrates. The aldehydes react readily with primary amines on the proteins to form a Schiffs base linkage. Because typical proteins display many lysines on their surface as well as the generally more reactive alpha-amine at their amino termini, they can attach to the slide in a variety of orientations, permitting different sides of the protein to interact with other proteins or small molecules in solution. Following attachment of the proteins to these slides, the unreacted aldehydes are quenched and nonspecific binding minimized by immersing the slides in a buffer containing bovine serum albumin (BSA).
- Although appropriate for most applications, aldehyde slides cannot be used when peptides or very small proteins are printed, presumably because the BSA obscures the molecules of interest. For such applications, BSA-NHS slides that are fabricated by first attaching a molecular layer of BSA to the surface of glass slides and then activating the BSA with N,N′-disuccinimidyl carbonate are used. The activated lysine, aspartate, and glutamate residues on the BSA react readily with surface amines on the proteins to form covalent urea or amide linkages. The slides are then quenched with glycine.
- Aldehyde slides can be purchased from TeleChem International (Cupertino, Calif.). BSA-NHS slides, displaying activated amino and carboxyl groups on the surface of an immobilized layer of bovine serum albumin (BSA), can be fabricated as follows. 10.24 g N,N′-disuccinimidyl carbonate (100 mM) and 6.96 ml N,N-diisopropylethylamine (100 mM) were dissolved in 400 ml anhydrous N,N-dimethylformamide (DMF). 30 CMT-GAP slides (Corning Incorporated, Coming, N.Y.), displaying amino groups on their surface, were immersed in this solution for 3 hours at room temperature. The slides are rinsed twice with 95% ethanol and then immersed in 400 ml of phosphate buffered saline (PBS), pH 7.5 containing 1% BSA (w/v) for 12 hour at room temperature. The slides are rinsed twice with ddH 2O, twice with 95% ethanol, and centrifuged at 200 g for 1 min to remove excess solvent. The slides are then immersed in 400 ml DMF containing 100 mM N,N′-disuccinimidyl carbonate and 100 MM N,N-diisopropylethylamine for 3 hour at room temperature. The slides are rinsed four times with 95% ethanol and centrifuged as above to yield BSA-NHS slides. The slides are stored in a desiccator under vacuum at room temperature for up to two months without noticeable loss of activity.
- Proteins are dissolved in 40% glycerol, 60% PBS, pH 7.5 at a concentration of 100 μg/ml unless indicated otherwise. The proteins are spotted on aldehyde slides using a GMS 417 Arrayer (Affymetrix, Santa Clara, Calif.). Following a 3 hours incubation in a humid chamber at room temperature, the slides are inverted and dropped onto a solution of PBS, pH 7.5 containing 1% BSA (w/v). After 1 minute, the slides were turned right side up and immersed in the BSA solution for 1 hour at room temperature with gentle agitation. Following a brief rinse in PBS, the slides are ready for further processing.
- Proteins of interest can be labeled with a fluorophore and hybridized to the array. The fluorescence of the fluorophore will increase in response to an amount of exciting radiation when the labeled protein is near the metal surface, preferably form about 50 Å to about 2000 Å, more preferably from about 50 Å to about 200 Å, from the metal surface. In another embodiment, the protein probe of interest can be labeled with an acceptor and donor fluorophore such that when the protein probe binds to a protein on the microarray, the protein probe is positioned near the metal surface such that fluorescence energy transfer is increased from the donor to the acceptor molecule. In still another embodiment, the protein affixed to the metal coated microarray surface can be labeled with a donor or acceptor molecule, and the protein probe can be labeled with acceptor or donor molecule respectively such that when the protein probe hybridizes with a labeled protein on the microarray surface, the fluorescence energy transfer from the donor molecule to the acceptor molecule is increased in response to an amount of exciting radiation.
- Thus, another embodiment of the present invention provides a microarray system including a solid support, wherein the solid support is coated with metal particles, preferably noble metal particles, most preferably with silver particles; and a matrix having an array of biomolecules, preferably nucleic acids or amino acids, at desired lengths attached to the support such that when a labeled probe hybridizes to a sequence of the biomolecules, preferably such that the label is positioned about 50 Å to about 2000 Å, preferably from about 50 Å to about 200 Å from a metal particle, the fluorescence of the labeled probe is increased in response to an amount of exciting radiation. The term “probe” includes proteins, nucleic acids, amino acids, oligonucleotide, peptide nucleic acids, peptides, or other molecules that hybridize, bind, or are complementary to the molecules of the matrix attached to the metal coated surface of the microarray.
- The efficiency of light harvesting assemblies based on RET (Adronov et al. (2000) J. Am. Chem. Soc. 122, 1175-1185; Swallen et al. (1999) J. Molec. Structure 485-486:585-597) can be increased or the extent of RET between donors and acceptors within cells (Gonzalez et al. (1995). Biophys. J. 69, 1272-1280; (Ng et al. (1999) Science 283, 2085-2089) but close to metallic particles can be increased. The phenomenon of metal-enhanced RET provides a unique opportunity of using the proximity of donor-acceptor pairs to metallic particles to modify the rates of transfer. Such effects are unique because the metal particles or surfaces, rather than the solution composition, can be used to modify the spectral properties of the probes.
- Another embodiment of the present invention provides a method for increasing the fluorescent intensity of a fluorophore including the steps of positioning a fluorophore adjacent to a metal particle, and exciting the fluorophore with a plurality of photons, commonly referred to as multi-photon excitation. Typically, the fluorophore is excited with short picosecond or fentosecond laser pulses with a wavelength approximately twice the longest single photon absorption maximum. Multi-photon excitation instrumentation and methodology are known in the art, and can be found, for example, in Topics in Fluorescence Spectroscopy,
Volume 5, Nonlinear and Two-Photon-Induced Fluorescence, Edited by Joseph R. Lakowicz. Plenum Press, New York, 1997, which is incorporated by reference herein in its entirety. Generally, multi-photon excitation is typically performed with a strongly focused laser light source, such as, a mode-locked titanium sapphire laser, providing pulses approximately 100 fentoseconds long, repetition rate near 80 MHz, with a wavelength range from 700 to 900 nm. Multi-photon excitation can also be accomplished with picosecond dye lasers. - Another embodiment of the present invention provides a method for increasing multi-photonic fluorescent intensity of a biomolecule including the steps of positioning a biomolecule adjacent to a metal particle, and exciting the biomolecule with a plurality of photons.
- Yet another embodiment of the present invention provides a method for selectively enhancing the region of electromagnetic emission of a sample including the steps of directing a metal particle to a region of interest in the sample, and providing an amount of exciting radiation in the sample.
- Another embodiment of the invention provides a method for selectively enhancing the region of electromagnetic emission of a sample including the steps of directing a metal particle to a region of interest in the sample, contacting the sample with a fluorophore, exposing the sample to an amount of exciting radiation. Exemplary metals are noble metals. The metal particle can be positioned using electric potential, magnetisim, or gravity.
- Still another embodiment provides a method for selectively enhancing the region of electromagnetic emission of a sample, the method including the steps of directing a metal particle to a region of interest in the sample, providing an amount of exciting radiation in the region of interest. Samples can be living cells, tissues, organs, or fluid samples in containers. The metal particle can be positioned using electromagnetic fields, or the metal particle can be linked to a protein, antibody, nucleic acid or the like. An antibody linked to a metal particle can be used to bring the metal adjacent to molecules recognized by the antibody. Thus, if the antibody recognizes a particular biomolecule, the metal can be positioned next to such biomolecule such that the fluorescence intensity of the biomolecule will increase in response to an amount of exciting radiation.
- Another embodiment discloses a method for selectively enhancing the region of electromagnetic emission of a sample, said method including the steps of directing a metal particle to a region of interest in the sample, contacting the sample with a fluorophore, and exposing the sample to an amount of exciting radiation. In a preferred embodiment, the fluorophore has a quantum yield of less than 0.8, preferably less than 0.5, more preferably less than 0.2, and most preferably less than 0.1. Fluorophores with low quantum yields will not fluoresce detectably unless they are adjacent to a metal particle. Thus, when the sample is exposed to an amount of exciting radiation, only the fluorophores adjacent to a metal particle will fluoresce enough to be detectable. Still another embodiment discloses a kit for detecting the presence of an analyte comprising an antibody capable of binding to said analyte, the antibody linked to a fluorophore having a quantum yield of less than about 0.5, preferably less than about 0.2, most preferably less than about 0.1, and at least one quartz surface having metal islands deposited thereon. Exemplary antibodies are directed to proteins, peptides, and other biomolecules.
- Another embodiment discloses a method for detecting an analyte, the method including the steps of labeling a first antibody with a donor, labeling a second antibody with an acceptor, contacting a sample with the first and second antibodies to form a complex with the analyte, positioning the analyte about 50 to about 2000 Å, preferably from about 50 Å to about 200 Å, from a metal particle, preferably a noble metal, providing an amount of exciting radiation, and detecting the analyte based on the increase in energy transfer from donor to acceptor. Exemplary donors are fluorophores with wavelengths which overlap the absorption spectra of the acceptor.
- Exemplary acceptors have absorption spectra which overlap with the emission spectra of the donors. Acceptors may also be fluorescent. Exemplary donor-acceptor pairs include fluorescein-rhodimine, DAPI-propidium iodide, and Cy3-Cy5. The antibodies can be labeled using standard techniques. In one embodiment, the complex can be positioned using gravity, electric potential, or other known force.
- Metal particles or metal particle films are known and can be produced using known methods. The following example uses silver but it will be appreciated that any metal can be used, preferably noble metals. Chemicals used to generate silver particles, silver nitrate (99+%), sodium hydroxide (pellets, 97%), ammonium hydroxide (NH 3 content 28-39%), and D-glucose (99.5%) were purchased from commercial suppliers and used without further purification. All procedures were performed using distilled water which was further purified by Millipore filtration. Silver islands were formed on quartz microscope slides. Quartz provided UV transmission and less autofluorescence. The quartz slides used to deposit silver particles were soaked in a 10:1 (v/v) mixture of H2SO4 (95-98%) and H2O2 (30%) overnight before the deposition. They were washed with water and air-dried prior to use.
- Silver deposition was carried out in a clean 30-ml beaker equipped with a Teflon-coated stir bar. To a fast stirring silver nitrate solution (0.22 g in 26 ml of Millipore filtered water), eight drops of fresh 5% NaOH solution was added. Dark-brownish precipitates were formed immediately. Less than 1 ml of ammonium hydroxide was then added drop by drop to redissolve the precipitates. The clear solution was cooled to 5° C. by placing the beaker in an ice bath, followed by soaking the cleaned and dried quartz slides in the solution. At 5° C., a fresh solution of glucose (0.35 g in 4 ml of water) was added. The mixture was stirred for 2 min at that temperature. Subsequently, the beaker was removed from the ice bath. The temperature of the mixture was allowed to warm up to 30° C. As the color of the mixture turning from yellow-greenish to yellow, the color of the slides become greenish, the slides were removed and washed with water and bath sonicated for 1 min at room temperature. After being rinsed with water several times, the slides were stored in water for several hours prior to the experiments.
- Emission spectra were obtained using a SLM 8000 spectrofluorometer. Intensity decays were measured in the frequency-domain using instrumentation described previously (Lakowicz et al. (1985) Biophys. Chem. 21, 61-78; Laczko et al. (1990) Rev. Sci. Instrum. 61, 2331-2337). For rhodamine 6G (R6G) and rose bengal (RB) the excitation was at 514 nm from the approximate 78 MHz output of a mode-locked argon ion laser. For the frequency-domain measurements the emission was observed through a 580 interference filter. For all steady state and frequency-domain measurements the excitation was vertically polarized and the emission observed through a horizontally oriented polarizer to minimize scattered light. The FD intensity decay data were analyzed in terms of the multi-exponential model
-
- FIG. 1A shows the experimental geometry of the silver islands on quartz slides, and FIG. 1B shows the absorption spectra of silver island films. This spectrum indicates that the particles are sub-wavelength in size. In the small-particle limit the absorption maximum due to this plasmon resonance is expected to be near 380 DM (Kerker, M. (1985) J. Colloid Interface Sci. 105, 297-314; Mulvaney, P. (1996) Langmuir, 12, 788-800). The absorption maximum above 400 nm can be due to an asymmetric effective shape of the particles with an axial ratio near 1.5 to 1.0 (Kerker, M. (1985) J. Colloid Interface Sci. 105, 297-314) and is also consistent with silver particles with spherical dimensions near 40-50 nm (Rivas et a l. (2001) Langmuir 17, 574-577; Jensen, et al. (2000) J. Phys. Chem. B 104, 10549-10556; Singer et al. (1995) J. Opt. Soc. Am. B, 12, 220-228). The shape and size distribution of the particles is almost certainly heterogeneous, but it is clear the particles are sub-wavelength in size.
- To determine the effects of silver islands on fluorescence, samples containing fluorophores were placed between two such silver island plates. From the absorption spectra of rose bengal, between two quartz plates, or two silver island coated plates (FIGS. 2A-2C). The distance between the plates is about 1 to 1.5 μm.
- As an initial experiment, the emission spectra of rhodamine B (RhB) and rose bengal (RB) between uncoated quartz plates (Q) or silver island films (S) were examined. These two fluorophores were selected because of their similar absorption and emission spectra but different quantum yields of 0.48 and 0.02 for RhB and RB, respectively. In the case of RhB the intensities are similar in the absence and presence of these silver islands (FIG. 3A). There may be a small decrease in the RhB intensity due to the silver islands, which may be due to the quenching effects of metals at short distances.
- Contrasting results were obtained for rose bengal (FIG. 3B). In this case the intensity increased about 5-fold in the presence of silver islands. It is important to recognize that the increased intensity observed for RB represents an underestimation of the quantum yield of RB near the silver islands. This is because only a small fraction of the RB molecules are within the distance over which metallic surfaces can exert effects. The region of enhanced fluorescence extends about 200 Å to about 2000 Å into the solution. Hence only about 4% of the liquid volume between the plates is within the active volume. The low percentage of active volume suggests that the quantum yield of RB within 200 Å of the islands is increased 125-fold. This increase is larger than possible if the quantum yield of 0.02 is correct and reflects an increased incident field because of the metal particles. Nonetheless, the spectra for RB in FIG. 3 indicates a substantial increased in quantum yield for the molecule within 200 Å of the silver islands.
- The effect of a concentrated electric field is not the dominant cause of the intensity increase for rose bengal in FIG. 3B. The emission occurs for RhB molecules both near to and distant from the silver islands. The field concentration effects could be masked by a dominant emission from the RhB molecules distant from the silver islands.
- The effects of an increased radiative rate and concentrated electric field can be distinguished by lifetime measurements. An increase in the radiative rate will decrease the lifetime; whereas, an increased rate of excitation will not change the lifetime. The intensity decays of RhB and rose bengal in the absence and presence of silver islands were measured (FIGS. 4A-4C and FIGS. 5A-5C). In a standard cuvette the intensity decay of RhB was found to be a single exponential with a lifetime τ=1.56 ns (FIG. 4A). In the presence of silver islands the intensity decay becomes strongly heterogeneous (FIG. 4C).
- The data could fit two decay times with the long lifetime of 1.81 ns being comparable to that found in a cuvette. Between silver islands, a short lifetime of 0.14 ns appeared which is attributed to RhB molecules in close proximity to the silver islands. The fractional steady state intensity of this short component is about 10%. Control measurements showed that this component was not due to scattered light. Measurements were also performed for RhB between quartz plates without silver islands. In this case the decay was also double exponential, but less heterogeneous than in the presence of islands. Nonetheless, it is clear that a short lifetime component appears for RhB between silver islands (FIG. 4B). Control measurements showed there was no significant intensity for the quartz slides alone without RhB. This result suggests that scattered light is not the origin of the short component seen for RhB between uncoated slides.
- Frequency-domain (FD) intensity decays for rose bengal are shown in FIGS. 5A-5C. In a cuvette the decay in a single exponential with τ=94 ps. The decay become slightly heterogeneous for rose bengal between uncoated quartz plates. However, the intensity decay of rose bengal changed dramatically when between silver islands. In this case the dominant lifetime became a 6 ps component, which corresponds to rose bengal molecules adjacent to the silver islands.
- The effects of silver islands on the intensity decays of RhB and rose bengal can be seen in the time-resolved decays reconstructed from the frequency-domain data (FIGS. 6A and 6B). For both fluorophores the intensity decay shows long decay time components essentially identical to the values observed in cuvettes. Silver islands result in the appearance of short decay times. The larger contribution of the short decay times for rose bengal can be understood from its lower quantum yield in bulk solution. RhB has a higher quantum yield so that its emission is detected from molecules throughout the 1 μm thick sample. Rose bengal has a low quantum yield in solution so the observed emission is mostly due to rose bengal molecules near the silver islands. The results from RhB and rose bengal were consistent with expectations.
- A number of additional fluorophores between uncoated quartz plates and between silver island films were examined to account for the contributions of artifacts. Emission spectra of four fluorophores (Erb, BF, [Ru(bpy) 3]2+, and [Ru(phen)2dppz]2+) are shown in FIGS. 7A-7D. In all cases the emission was more intense for the solutions between the silver islands. For example, [Ru(bpy)3]2+ and [Ru (phen)2dppz]2+ have quantum yields near zero, respectively (Van Houten et al. (1975) J. Am. Chem. Soc. 97, 3843-3844; Harriman, A. (1977) J. Chem. Soc., Chem. Commun. 777-778; Nair et al. (1997) Inorg.Chem. 36, 962-965; Turro et al. (1995) J. Am. Chem. Soc. 117, :9026-9032). A larger enhancement was found for [Ru(phen)2 dppz]2+ than for [RU(bpy)3]2+.
- The enhancements for 10 different fluorophore solutions are shown in FIG. 8. In all cases lower bulk-phase quantum yields result in larger enhancements for samples between silver island films. Additionally, [Ru(phen) 2dppz]2+ in water-dimethylformamide (DMF) mixtures were examined (FIG. 9). This compound is quenched by water and the largest enhancements were observed for the most-quenched solution (FIG. 9). The results in FIGS. 7-9 provide strong support for the assertion that proximity of the fluorophore to the metal islands resulted in increased quantum yields. It is unlikely that these diverse fluorophores would all bind to the silver islands or display other unknown effect results which resulted in enhancements with increased monotonically with decreased quantum yields.
- FIGS. 10A and 10B show the emission spectra of two solvent sensitive fluorophores between quartz plates (Q) and silver islands (S). In both cases blue shifts in the emission, which are consistent with a decreased lifetime of fluorophores near the islands were observed. Because fluorophores within 50 Å of the metal are likely to be quenched, it is unlikely that the blue shifts seen in FIG. 10A and FIG. 10B are due to fluorophores bound to the silver islands. Binding of fluorophores to the uncoated quartz surface is also unlikely because uncoated quartz is present for both emission spectra.
- The protein E. coli β-galactosidase and human glycoxidase were obtained from commercial suppliers. The proteins were dissolved in 10 mM phosphate buffer, pH 6.5. The concentrations of β-galactosidase and human glyoxylase were 0.05 and 0.15 mg/ml, respectively. For studies of intrinsic protein fluorescence the excitation wavelength was 295 nm. The emission spectra of two proteins in the presence and absence of silver islands were examined (FIGS. 11A and 11B). The proteins β-galactosidase and human glyoxylase were selected for their modest and low quantum yields. β-galactosidase has a quantum yield approximately equal to that of N-acetyl-L-tryptophamide (NATA) (D'Auria et al. (2001) J. Biochem., in press) which is reported to be 0.13 (Demchenko, A. P. (1981). Ultraviolet Spectroscopy of Proteins, Springer-Verlag, New York.). The quantum yield of human glyoxylase was found to be about 10-fold less, and thus near 0.013. For the higher quantum yield β-galactosidase there was no significant effect of the silver islands on the emission spectra. For the lower quantum yield human glyoxylase are observed both a blue shift and an increase in emission intensity. β-galactosidase is a tetrameric protein, 480,000 molecular weight, which contains 26 tryptophan residues in each 120,000 dalton subunit (Jacobson et al. (1994) Nature 369, 761-766). Human glyoxylase is a 66,000 dalton monomer which contains two tryptophan residues (D'Auria, S., unpublished results). The spectra changes in FIG. 11B are due to increased emission from a highly quenched tryptophan residue in glyoxyalase which is shielded from the solvent. The absence of a spectral shift or enhancement in β-galactosidase is understandable given its large number of tryptophan residues and it being unlikely that a significant fraction was highly quenched. Thus, silver islands can result in increased emission from quenched aromatic amino acid residues in proteins.
- Adenine, thymine and calf thymus DNA were obtained from commercial suppliers. Poly T and poly C, each 15 bases long, were obtained from the Biopolymer Core facility at the University of Maryland, Baltimore School of Medicine. Emission spectra of the bases adenine and thymine are shown in FIGS. 12A and 12B, showing increased emission in the presence of the silver islands. Similar results were obtained for the single stranded nucleotides poly T and poly C (FIGS. 13A and 13B). The long wavelength emission maxima of poly C is in agreement with that reported previously (Plessow et al. (2000) J. Phys. Chem. B 104, 3695-3704). 1119] Calf-thymus DNA was dissolved in 50 mM Tris, pH =7. The DNA concentration was 5 mM as base pairs. Emission spectra were measured on a SLM 8000 spectrofluorometer with 287 nm excitation. Frequency-domain lifetime measurements were obtained on a 10 GHz instrument (Laczko et al. (1990) Rev. Sci. Instrum. 61, 2331-2337; Lakowicz et al. (1994) Biophys. J. 46, 463-477). The excitation source was a cavity-dumped rhodamine 6G dye laser providing approximately 100 ps pulses which were frequency-doubled at 287 nm. Intensity decays were measured through a combination 344 nm interference filter plus a WG 335 long pass filter, which provided transmission from about 330 to 355 nm. Emission spectra and lifetimes were measured with vertically polarized excitation and horizontally polarized emission. This optical configuration reduced scattered light of the excitation wavelength without significant distortion of the spectra or lifetimes. The frequency-domain data were fit to the multi-exponential model where the intensity decay is given by equation (1) above where αi are amplitude factors associated with each decay time τi. The sum of the αi values are normalized to unity, Σαi=1.0.
- If the mass thickness is restricted to near 40 Å, one obtains particles on the surface with sub-wavelength dimensions, as can be seen from the characteristic surface plasmon absorption spectrum which are close to the small wavelength limit (FIG. 1B). The DNA samples were placed between two such silver islands plates with a separation near 1-1.5 μm. The absorption spectrum for DNA between the plates is approximately the sum of the DNA and silver island absorption (FIGS. 14A and 14B), which suggests that the islands did not significantly change the extinction coefficient of the DNA.
- The emission spectrum of DNA was examined in a thin 0.1 mm cuvette and between the two island films (FIGS. 15A and 15B). Excitation at 287 nm probably resulted in partially selective excitation of the adenine and guanine residues (Wilson et al. (1980) Photochem. & Photobiol. 31, 323-327; Georghiou et al. (1996) Biophys. J. 70, 1909-1922). Surprisingly, the emission is about 80-fold more intense near the metal islands. It is important to note that this 80-fold increase is a considerable underestimate of the increase displayed by DNA near the particles. The region of enhancement is expected to extend about 200 Å to about 2000 Å into the solution. Taking into account the two island film surfaces, only about {fraction (1/25)} of the DNA is near the silver. This suggests that the emission of DNA near the silver is enhanced 2000-fold. This is near the maximum enhancement predicted for a molecule at the optimal distance from an ellipsoid of appropriate size and shape. Amplified field effect can result in a maximum of 140-fold enhancement (Gersten et al. (1981) J. Chem. Phys. 75, 1139-1152) suggesting a minimum of a 15-fold increase in the quantum yield of the DNA near the island films. It is unlikely that the field enhancement is maximal. The actual increased quantum yield of DNA is between about 15-fold and less than about 2000-fold.
- One explanation of the increased intensity seen in FIG. 15B could be a decrease in the non-radiative decay rate k nr, which would result in a longer lifetime. Another reason for the increased emission could be an amplified incident light field. This effect would result in increased intensity, but is the lifetime would be unchanged. Frequency-domain intensity decays are shown in FIGS. 16A and 16B. These measurements were used to reconstruct the more intuitive time-domain decays (FIG. 17). The decays are multi-exponential in the absence or presence of metal islands (Table 1). The intensity decays were strongly heterogeneous or multi-exponential, which can be seen from the range of decay time from 60 ps to 4.56 ns. The individual lifetimes of DNA are uncertain because of its weak intrinsic fluorescence, but the mean lifetimes ({overscore (τ)}) are reliable. Such a wide range of lifetimes are in agreement with other published reports (Ballini et al. (1983) Biophys. Chem. 18, 61-65; Georghiou et al. (1985) Photochem. & Photobiol. 41, 209-212; Plessow et al. (2000) J. Phys. Chem. B 104, 3695-3704). The important conclusion from these experiments is that the mean lifetime ({overscore (τ)}) of DNA decreased under the same conditions which we observed on 80-fold increase in intensity (FIG. 15B). Such a decreased lifetime cannot be explained by a decrease in knr or increased rate of excitation. However, the decreased lifetime can be explained by an increase in the radiative decay rate. Let Γm represent the rate of the radiative decay due to presence of the metal particles. This new rate changes the quantum in the presence of metal (m) to
-
- The quantum yields and lifetimes in the absence of metals are given by the
1 and 2 with Γm=0.0. Hence an increase in the radiative decay rate of DNA by the metal can explain both the increased intensity and decreased lifetime in the presence of the silver islands. There is no quantitation agreement between the 80-fold increase in intensity and the 3-fold decrease in lifetime. There are numerous possible reasons, including different spatial averaging across the sample by the intensity and lifetime measurements. Nonetheless, the intrinsic DNA lifetime decreased while the intensity increased, demonstrating an increase in the rate of radiative decay.equations TABLE 1 Fluorescence intensity decay parameters of calf thymus DNA in 50 mM TRIS, pH 7.0, 20° C. CONDITIONS {overscore (τ)}(ps) a) α1 τ1 (ps) α2 τ2 (ns) α3 τ3 (ns) XR 2 b) 0.1 mm cuvette 60 0.974 12 0.021 1.17 0.005 4.56 2.7 on silver islands 19 0.989 5 0.007 0.59 0.004 2.38 3.2 - Resonance energy transfer (RET) is widely used in biochemical and biomedical research (Morrison et al. (1993) Biochemistry 32, 3095-3104; Ju et al. (1996). Nat. Med, 292, 246-249). RET occurs whenever fluorophores with suitable spectral properties come within the Forster distance R0. Förster distances range from 20-40Å, and are rarely larger than 50 Å. The effects of silver island films on RET between rhodamine 6G (R6G) and sulforhodamine 101 (SR101) when dissolved in homogeneous solution were examined. Emission spectra of this mixture are shown in FIG. 18, normalized to the donor emission. Silver islands result in an increase in the acceptor emission near 590 nm. While this increase may appear modest, it is substantial for a mixture of fluorophores in which the acceptors are present at a concentration of 0.2 mM resulting in significant direct excitation of the acceptor.
- Additionally, RET of DAPI to acridine orange (AO) when bound to double helical calf thymus DNA was examined (FIG. 19). In this case the bulk concentration of the donor and acceptor are lower because they are held in close proximity by the DNA. There is a dramatic increase in the acceptor emission near 520 nm which we believe is due to a metal-enhanced increase in the extent of energy transfer.
- Calf thymus DNA was obtained from commercial suppliers and dissolved in 50 mM tris buffer,
pH 7 to a concentration of 2 mM in base pairs using 13,300 M−1 cm−1 per base pair. DAPI and propidium iodide (PI) were obtained commercially. For the energy transfer measurements the DAPI and PI concentrations were 1.5×10−5 M and 1.5×10−4 M, respectively. These concentrations result in 133 base pairs per DAPI molecule and 13 base pairs per PI molecule. - Emission spectra were obtained using a SLM 8000 spectrofluorometer using 360 nm excitation. Intensity decays were measured in the frequency-domain using instrumentation described previously (Laczko et al. (1990) Rev. Sci. Instrum. 61, 2331-2337; Lakowicz et al. (1994) Biophys. J. 46, 463-477). The excitation wavelength of 360 nm was obtained from the frequency-doubled output of a 3.80 MHz cavity dumped
Pyridine 2 dye laser with a 10 ps or less pulse width. - For the frequency-domain measurements the emission was observed through a 460 nm interference filter. For steady state and frequency-domain measurements the excitation was vertically polarized and the emission observed through a horizontally oriented polarizer to minimize scattered light. The FD intensity decay were analyzed in terms of the multi-exponential model using equation (1) above where τ i are the lifetimes with amplitudes αi and Σα i=1.0. Fitting to the multi-exponential model was performed as described previously (Lakowicz et al. (1994) Biophys. J 46, 463-477). The contribution of each component to the steady state intensity is given by equation (2) above.
-
-
- The base pair length 3.4 Å and r min=12 Å were fixed parameters.
- Silver particles were obtained by chemical reduction of silver onto quartz slides as above. If the mass thickness of the deposition silver is kept near 40 Å the silver particles have sub-wavelengths dimensions and display the characteristics of surface plasmon absorption (FIG. 1). From studies of the absorption spectra of dyes between two such silver island films the sample thickness was found to be near 1 to 1.5 μm.
- To examine the effect of silver islands on resonance energy transfer double helical calf thymus DNA which was labeled with DAPI as the donor and/or PI as the acceptor was used. Emission spectra of DAPI-DNA and DNA labeled with both DAPI and PI in a cuvette are shown in FIG. 20. The extent of energy transfer is about 20%, as can be seen from the decrease in the DAPI donor intensity near 460 nm. The PI acceptor makes only a small contribution to the emission seen at 610 nm. The extent of energy transfer near 20% is consistent with the R 0 value of 35.7 Å for this D-A pair (Murata et al. (2000) Biopolymers(Biospectrosc.) 57, 306-315). Based on the extent of acceptor labeling of one per 13 base pairs, and 3.4 Å per base pair in the DNA helix, the acceptor molecules are on average 45 Å apart.
- Next, the effects of the silver island films on DNA labeled with only the DAPI donor or only the PI acceptor were examined (FIG. 21). In the case of DAPI-DNA the intensity is essentially unchanged when placed between quartz plates or between silver island film. In the case of PI-DNA there is an approximate 2-fold increase in the PI intensity. The larger effect of the silver island film on PI-DNA is consistent with its lower quantum yield near 0.15 as compared to 0.53 for DAPI-DNA (Murata et al. (2000) Biopolymers (Biospectrosc.) 57, 306-315).
- The emission spectra of donor and acceptor-labeled DNA are shown in FIG. 22. A remarkable increase in the PI acceptor emission was found for the DNA sample between the two silver island films as compared to between two unsilvered quartz plates. The silver island film had only a modest effect on acceptor-only DNA (PI-DNA). These results show an increase in the efficiency of RET from DAPI to PI due to proximity to the silver islands.
- An increase in energy transfer from DAPI to PI is expected to result in a decrease in the DAPI decay time. Frequency-domain intensity decay of DAPI are shown in FIG. 23. The dashed lines in each panel show the DAPI decays in the absence of the PI acceptor. In all cases the mean DAPI lifetimes decreased in the presence of PI (Table 2). The mean DAPI decay time ({overscore (τ)}=2.93 ns without acceptor) was reduced about 20% to τ=2.39 ns in the presence of the silver island, while the steady state intensity was essentially unchanged (FIG. 21). This result suggests an increase in the rate of radiative decay due to the silver islands. Control measurements showed the absence of scattered light in all these measurements.
TABLE 2 Multi-exponential analysis of DAPI donor intensity decay in the presence and absence of acceptor and silver islands Sample1 {overscore (τ)} (ns)2 τ (ns)3 α1 τ1 (ns) α2 τ2 (ns) α3 τ3 (ns) XR 2 DAPI-DNA, C 2.93 2.42 0.278 0.63 0.722 3.11 — — 2.1 DAPI-DNA, Q 2.80 1.58 0.311 0.16 0.391 1.15 0.298 3.62 2.2 DAPI-DNA, S 2.39 1.10 0.447 0.09 0.414 1.29 0.139 3.70 2.1 DAPI-PI-DNA, C 2.16 1.04 0.427 0.11 0.308 0.84 0.265 2.77 1.0 DAPI-PI-DNA, Q 2.26 0.80 0.467 0.08 0.367 0.66 0.166 3.15 1.7 DAPI-PI-DNA, S 1.67 0.24 0.769 0.04 0.172 0.40 0.059 2.44 3.2 - DAPI donor decay was examined when the donor and acceptor-labeled DNA is in a 0.5 mm cuvette, between plain quartz plates, and between silver island films (Table 2). The mean DAPI lifetime was not changed going from the cuvette to the unsilvered quartz plates, {overscore (τ)}=2.16 and 2.26 ns, respectively. A dramatic decrease in the DAPI decay time to {overscore (τ)}=1.67 ns was found for DAPI-DNA between the silver island films (FIG. 23A C). This decrease in lifetime is attributable to the increased in RET seen in the emission spectra (FIG. 22).
- The frequency-domain donor decays in terms of the apparent Forster distance were analyzed. This was accomplished by analyzing the donor decay. The acceptor concentration was held constant at 0.075 acceptors per base pair and the values of R 0 were allowed to vary to obtain the best fit to the data (FIG. 24A-C). The value of R0=37.4 Å is close to that calculated for the D-A pair, R0=35.7 A. The apparent value of Ro decreased to 33.5 A between the quartz plates. Importantly, the apparent value of R0 increased 2-fold to 75.6 Å for the sample between the silver island films. This is an apparent R0 value. Examination of this fit (FIG. 24C) reveals that the frequency-domain intensity decay could not be fit to a single R0 value. This lack of fit suggests the presence of at least two populations of D-A pairs, with the pairs close to the silver islands displaying a larger R0 value.
- It is important to recognize that the 2-fold increase in the apparent value of R 0 represents a minimum estimate of the effect of the silver islands on RET. The active space near the silver islands extend approximately 200 Å to about 2000 Å into the solution. Assuming a sample thickness of 1 μm only about {fraction (1/25)} of the sample is within the active value. This suggests that the actual effect on RET is greater than a 2-fold increase in R0.
- RhB, Eosin sodium salt, rose bengal and
coumarin 152 were obtained from commercial suppliers. The experimental sample geometry is shown in FIG. 25. Two-photon excitation of RhB, eosin and rose bengal was accomplished with the 852 nm output of a Tsunami mode-locked Ti:Sapphire laser, 80 MHz repetition rate, 90 fs pulse, about 0.5 W average power. For C152 and ANS the multi-photon excitation wavelength was near 800 nm. The excitation was focused on the sample with a 15 cm radius concave mirror. The solution was placed between two high quality quartz plates, λ/4 flatness. The plates were half uncoated and half coated with silver islands as described above. From absorption measurements the thickness of the samples between the plates was about 1 μm. This sandwich sample was mounted on a x-y positioner. The focused spot of the laser was about 4 mm in length and 30 μm in diameter. The x-y positioner was used to move the sample so the laser illuminated regions with or without silver islands. This position change was accomplished without any change in the experimental geometry. Scattered excitation was eliminated with a combination of a heat filter and BG-38 glass filter for the emission spectra and a BG-38 and a 580 nm interference filter for time-resolved measurements. - Intensity decays were measured in the frequency-domain using instrumentation described previously (Lakowicz et al. (1985) Biophys. Chem. 21, 61-78; Laczko et al. (1990) Rev. Sci. Instrum. 61, 2331-2337). For the frequency-domain measurements the emission was observed through a 580 interference filter. For all steady state and frequency-domain measurements the excitation was vertically polarized and the emission observed through a horizontally oriented polarizer to minimize scattered light. The FD intensity decay were analyzed in terms of the multi-exponential model using equation (1) above where τi are the lifetimes with amplitudes αi and Σαi=1.0. Fitting to the multi-exponential model was performed as described previously (Lakowicz et al. (1994) Biophys. J. 46, 463-477). The contribution of each component to the steady state intensity is given by equation (2) above. The mean decay time is given by equation (5) above.
- The emission spectra of RhB between silver island films with two-photon excitation at 852 nm was examined (FIG. 26A). The emission intensity for RhB between the metal particles (indicated as—in FIG. 26A) was increased about 4-fold relative to RhB between uncoated quartz plates (indicated as - - - in FIG. 26A). When the sample was first exposed to the focused 852 nm light, white light from the illuminated region was visibly detected. This “spark” decayed in less than one second, but some white light background remained. This white light was also seen from the silver islands alone without RhB (indicated as . . . in FIG. 26A). Such a white continuum emission for illuminated metal probes in near-field microscopy has been reported previously (Sanchez et al. (1999) Phys. Rev. Letts. 82, 4014-4017). Importantly, the RhB signal remained stable following the initial white light transient. RhB was also examined with one-photon excitation of 490 nm (FIG. 26, bottom). In this case there was almost no effect of the silver islands as compared to the uncoated quartz plates.
- As a control experiment, RhB with two-photon excitation in the presence of silver islands was examined, but with the plates rotated so that the islands were on the outer surface not in contact with RhB (FIG. 27). In this case no difference between the silvered and unsilvered plates were found. The white continuum emission was still observed from the silver islands. This result demonstrated that the enhanced emission of RhB seen by FIG. 26 is due to two-photon excitation of RhB, and not due to second harmonic generation by the metal particles which in turn excites RhB.
- The results in FIG. 26 can be understood by considering the nature of our layered sample (see FIG. 1). The fluorophore is uniformly distributed in the 1 μ thick sample. The region affected by the metal islands is expected to extend about 250 Å in the solution. Recalling that there were two silver island surfaces, we estimated that only about 5% of the solution is within the active area. In fact, even this percentage is probably too high because the fluorophores within 50 Å of the metal surface are typically quenched. Assuming 5% of the sample is affected by the metal, the 4-fold enhancement for RhB (FIG. 26, top) suggests an 80-fold enhancement of two-photon excitation due to the metal particles. The small fraction of fluorophores near the metal particles explains the absence of a significant effect with one-photon (FIG. 26, bottom) because the majority of the emission occurs from RhB molecules distant from the silver islands.
- The frequency-domain intensity decays of RhB between coated and uncoated quartz plates with one and two-photon excitation were examined. The excitation wavelength for FIG. 29A was 852 nm, and the observation wavelength was 580 nm. For one-photon excitation the mean lifetime was essentially unchanged between the coated or uncoated plates (FIGS. 28A-B). This result is consisted with FIG. 26B, which showed that most of the one-photon individual emission of RhB occurred from the bulk sample. Contrasting results were found for the intensity decay of RhB with two-photon excitation (FIGS. 29A-B). In this case the mean lifetime is dramatically shortened by the silver island films. The reduced RhB lifetime with 852 nm excitation is the result of localized two-photon excitation of RhB molecules near the metal particles. The reduced RhB lifetime also demonstrated that the excitation is not due to second harmonic generation by the metal islands. The lifetime of RhB resulting from excitation by the harmonic would be the same as that found in the bulk solution.
- In many applications of fluorescence, photostability of the fluorophore is a primary consideration. This is particularly true in single molecule detection where it has been estimated that approximately 1,000 photons can be observed from a highly stable fluorophore like rhodamine prior to photodestruction (Ambrose et al. (1999) Chem. Rev. 99, 2929-2956). Since photochemistry occurs in the excited state, a reduction in the fluorescence lifetime is expected to result in increased photostability. The photostability of Rhodamine B between coated and uncoated quartz slides with one- and two-photon excitation was examined (FIGS. 30A-B). For one-photon excitation, the photostability was unaffected by the presence or absence of silver islands (FIG. 30B). For two-photon excitation, photostability in the presence of silver islands was enhanced (FIG. 30A). These results are consistent with the shorter lifetime observed for Rhodamine B between silver islands and with the assertion that two-photon excitation is occurring preferentially near the silver island films.
- In the proceeding experiments, Rhodamine B was used which displays a quantum yield of 0.48 (Q=0.48) in bulk solution. As a result, much of the emission occurred from the bulk solution in regions unaffected by the silver islands. Multi-photon excitations occurring near the silver islands are increasing the quantum yield of the nearby fluorophores. FIG. 31A shows emission spectra for eosin (Q=0.24), and FIG. 31B shows the emission spectra for rose bengal (Q=0.02) between quartz plates and between silver island films. Excitation wavelength was 852 nm. In these spectra, the white light continuum resulting from the silver island films is more evident because of the lower overall signal. Importantly, with two-photon excitation, there is essentially no emission from eosin or rose bengal under conditions where there is substantial emission from the fluorophores between the silver islands. This result suggested selective and localized two-photon excitation near metal particles.
- The concept of selective excitation was pursued further using biochemically relevant fluorophores such as
coumarin 152 and ANS (FIG. 32A-B). In this case a remarkable enhancement of the two-photon induced emission for these fluorophores between silver island films was observed. In the case of ANS with a very low quantum yield in water (Q<0.01) there was essentially no signal seen for ANS between the uncoated slides, and even the signal observed from a bulk solution in a cuvette was insignificant compared to the two-photon induced emission in the presence of silver particles. The results shown in FIGS. 31A-B and 32A-B suggest that multi-photon excitation near silver particles is a general phenomenon which can result in highly localized excitation in regions near the metal particles. - FIG. 33 is an illustration of how fluorophores on metal colloids can be selectively detected by multi-photon excitation in the presence of free fluorophore. Only the fluorophores within about 50 to about 2000 Å, preferably from about 50 Å to about 200 Å, of a metal particle will have increased fluorescence when exposed to an amount of exciting radiation. The free fluorophores will not fluoresce at detectable levels.
- FIG. 34 is an illustration of localized multi-photon excitation of intracellular autofluorescence by metal colloids. In one embodiment, a metal particle, preferably a noble metal, is attached to an antibody that binds to a desired target. When the antibody binds to the desired target, the metal particle is positioned near the target at a distance sufficient to increase the fluorescence of the target, typically about 50 to about 2000 Å, preferably from about 50 Å to about 200 Å, in response to an exciting amount of fluorescence, preferably multi-photonic excitation. The antibody can be from any host animal capable of producing antibodies. Exemplary host animals include mammals, preferably rabbits, goats, horses, and humans. The antibody can also be conjugated with an extrinsic fluorophore.
- FIG. 35 depicts a schematic for an immunoassay assay. A capture antibody is covalently bound to the surface near the metal particles. The presence of the analyte (An) results in surface binding of a second antibody which is labeled with a non-fluorescent chromophore. Exemplary non-fluorescent or weakly fluorescent chromophores fluorophore include, but are not limited to, rose bengal, eosin, malachite green, and organic molecules used as dyes or stains in optical microscopy. Suitable organic molecules used as dyes or stains in optical microscopy are well known in the art and include, but are not limited to, acid fuchsin, alcian blue, alizarin red, congo red, crystal violet, eosin, evans blue, light green SF, luxol fast blue, methyl green, neutral red, nigrosin, oil red o, orange g, picric acid, pyronin y, safranine o, sirius red, sudan black b, and toluidine blue o. Upon binding to the antigen, the previously non-fluorescent species emits in response to an amount of exciting radiation due to the increased radiative rate. The unbound species more distant from the metal site will not interfere with the fluorescent signal because they do not fluoresce. The non-fluorescent species becomes a “molecular beacon” emitting only when close to the metal particles. It will be appreciated that antibodies or antibody fragments from any host capable of producing antibodies can be used. Exemplary hosts include mammals such as primates, goats, horses, rabbits, and rodents. Additionally, recombinant or chimeric antibodies can also be used. This assay can be used to detect the presence of an analyte in biologic fluids including, but not limited to, saliva, urine, mucus, blood, plasma, and lymphatic fluid. Exemplary analytes include steroids, small molecules, proteins, peptides, bacteria, and fungi.
- FIG. 36 depicts an assay of the present invention which uses electrical potential to gate the fluorescence on and off. A fluorophore is positioned at the end of a flexible polymer chain which is attached to a surface coated with metal particles In one embodiment, the entire chain and fluorophore are negatively charged. When the voltage or the metal is positive, the fluorophore is in the quenched zone. When the voltage is negative, the fluorophore is displaced into the enhancement zone. Alternatively, the fluorophore is moved in and out of the shorter range quenching zone of the metal. Thus, the emission is gated by the voltage. The electric potential can be generated using known techniques. Suitable sources of electric potential include devices capable of producing electricity including, but not limited to, batteries, fuel cells, and transformers. In another embodiment, a method to access array sensors using electric potential is provided using methods known for linking DNA or proteins in desired patterns on surfaces. For example, biomolecules can be linked to surfaces using adhesives, polymers, lysine, or biotin-avidin.
- Another embodiment of the present invention discloses an immunoassay in wherein a first antibody is labeled with a donor molecule and a second antibody is labeled with an acceptor molecule (FIG. 37). The labeled antibodies will bind to their respective antigens to form a complex. When the complex is near a metal particle, the resonance energy transfer from donor to acceptor is enhanced such that the emission from the acceptor is detectable. The complexes can be positioned near a silver island surface using electrical potential or other attractive forces. The metal-induced increased in the transfer rate results in transfer over larger distances, and the antigen is detectable by an increase in the transfer efficiency.
- FIG. 38 depicts another embodiment of the present invention, an apparatus for surface plasmon excitation. For the control surface without silver (FIG. 38B) the emission increases at the critical angle for the fluorescence. When excitation is at the plasmon resonance angle the emission is sharply distributed at the plasmon angle for the emission wavelength. A typical metallic surface for this purpose would be a continuous, semi-transparent silver coating. This coating may be further modified by binding of metallic colloids or particles to provide both enhanced and directional emission.
- Various modifications may be made to the invention as described without departing from the spirit of the invention or the scope of the appended claims.
Claims (27)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/073,625 US20020160400A1 (en) | 2001-02-14 | 2002-02-11 | Radiative decay engineering |
| US10/990,549 US7776528B2 (en) | 2001-02-14 | 2004-11-18 | Radiative decay engineering |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26832601P | 2001-02-14 | 2001-02-14 | |
| US10/073,625 US20020160400A1 (en) | 2001-02-14 | 2002-02-11 | Radiative decay engineering |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/990,549 Division US7776528B2 (en) | 2001-02-14 | 2004-11-18 | Radiative decay engineering |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20020160400A1 true US20020160400A1 (en) | 2002-10-31 |
Family
ID=23022467
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/073,625 Abandoned US20020160400A1 (en) | 2001-02-14 | 2002-02-11 | Radiative decay engineering |
| US10/990,549 Expired - Fee Related US7776528B2 (en) | 2001-02-14 | 2004-11-18 | Radiative decay engineering |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/990,549 Expired - Fee Related US7776528B2 (en) | 2001-02-14 | 2004-11-18 | Radiative decay engineering |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20020160400A1 (en) |
| EP (1) | EP1360332A4 (en) |
| JP (1) | JP2004524528A (en) |
| CA (1) | CA2438129A1 (en) |
| MX (1) | MXPA03007147A (en) |
| WO (1) | WO2002064837A1 (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030228682A1 (en) * | 2002-04-30 | 2003-12-11 | University Of Maryland, Baltimore | Fluorescence sensing |
| US20040087006A1 (en) * | 2002-10-28 | 2004-05-06 | Leica Microsystems Heidelberg Gmbh | Sample carrier for a confocal microscope and method for fabricating a sample carrier |
| DE10314579A1 (en) * | 2003-03-31 | 2004-10-14 | Carl Zeiss Jena Gmbh | Apparatus for sequence analysis of nucleic acids has channels with fixed metal particles, where the sample is moved past them with an excitation beam for fluorescence to be passed through spectral analysis for evaluation |
| US20040235185A1 (en) * | 2003-02-04 | 2004-11-25 | Carina Horn | Fluorimetric determination of analytes by amine-N-oxides as redox indicators |
| US20050202464A1 (en) * | 2001-02-14 | 2005-09-15 | University Of Maryland, Baltimore | Radiative decay engineering |
| US20060011862A1 (en) * | 2004-07-16 | 2006-01-19 | The Charles Stark Draper Laboratory, Inc. | Methods and apparatus for biomolecule identification |
| US20060024771A1 (en) * | 2004-07-26 | 2006-02-02 | University Of Louisville Research Foundation | Enhancement of sensitivity of fluorophore mediated biosensing and bioimaging |
| WO2006034045A1 (en) * | 2004-09-16 | 2006-03-30 | Ut-Battelle, Llc | Transparent solid-state structure for diagnostics of fluorescently labeled biomolecules |
| US20060147927A1 (en) * | 2002-11-26 | 2006-07-06 | Geddes Chris D | High-sensitivity assays for pathogen detection using metal enhanced fluorescence |
| US20060286680A1 (en) * | 2004-07-26 | 2006-12-21 | University Of Louisville Research Foundation | Fiber-optic biosensor and biosensing methods |
| US20080286880A1 (en) * | 2004-07-07 | 2008-11-20 | The Penn State Research Foundation | Methods and Systems for Nanoparticle Enhancement of Signals |
| US20090069743A1 (en) * | 2007-09-11 | 2009-03-12 | Baxter International Inc. | Infusion therapy sensor system |
| US20090130773A1 (en) * | 2005-10-13 | 2009-05-21 | Teck Choon Ayi | Method of Enhancing a Fluorescent Signal |
| WO2006088976A3 (en) * | 2005-02-16 | 2009-08-20 | Univ Louisville Res Found | Fiber-optic biosensor and biosensing methods |
| US20100144557A1 (en) * | 2006-01-17 | 2010-06-10 | Moore Wayne E | Plasmon fluorescence augmentation for chemical and biological testing apparatus |
| US20140038176A1 (en) * | 2010-11-11 | 2014-02-06 | Sony Corporation | Method of detecting nucleic acids, method of optically observing sample and fluorescent substance |
| US10982255B2 (en) * | 2012-05-10 | 2021-04-20 | Sony Corporation | Microchip for nucleic acid analysis |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2828284B1 (en) * | 2001-08-01 | 2003-10-31 | Bio Merieux | METHOD FOR DETECTION AT A SOLID SUPPORT OF A COMPLEXATION OR HYBRIDIZATION BETWEEN AT LEAST TWO MOLECULES BASED ON AN AMPLIFIED SIGNAL AT THE SUPPORT LEVEL |
| EP1825249B1 (en) | 2004-11-19 | 2015-12-30 | University Of Maryland Biotechnology Institute | Microwave accelerated assays |
| US8886464B2 (en) | 2005-01-03 | 2014-11-11 | University Of Maryland, Baltimore County | Microwave-accelerated metal-enhanced detection method |
| WO2012075220A2 (en) | 2010-12-01 | 2012-06-07 | University Of Maryland, Baltimore County | Assays for pathogen detection using microwaves for lysing and accelerating metal-enhanced fluorescence |
| US8980179B2 (en) * | 2006-05-17 | 2015-03-17 | University Of Maryland, Baltimore County | Angular-dependent metal-enhanced fluorescence |
| US20090092966A1 (en) * | 2006-05-31 | 2009-04-09 | Li-Cor, Inc. | Colloidal metal aggregates and methods of use |
| EP1870478A1 (en) * | 2006-06-20 | 2007-12-26 | Hitachi, Ltd. | Biosensor element and method for manufacturing the same |
| US9719923B2 (en) | 2007-07-18 | 2017-08-01 | University Of Maryland, Baltimore County | Tuning of metal enhanced emissions of long-lived luminescent compounds |
| EP2686683A4 (en) | 2011-03-18 | 2014-10-01 | Chris Geddes | Metal-enhanced photoluminescence from carbon nanodots |
| US9244012B2 (en) | 2011-09-26 | 2016-01-26 | University Of Maryland, Baltimore County | Enhanced luminescence from nanopolished surfaces and plate wells |
| US9816990B2 (en) | 2013-02-28 | 2017-11-14 | University Of Maryland, Baltimore County | Ultra-fast pathogen toxin detection assay based on microwave-accelerated metal-enhanced fluorescence |
| US10379050B2 (en) | 2015-01-13 | 2019-08-13 | University Of Maryland, Baltimore County | Spectral shifts and modifications in metal-enhanced fluorescence, phosphorescence and alpha-fluorescence |
| US10294451B2 (en) | 2015-04-22 | 2019-05-21 | University Of Maryland, Baltimore County | Flow and static lysing systems and methods for ultra-rapid isolation and fragmentation of biological materials by microwave irradiation |
| AU2019329686A1 (en) | 2018-08-27 | 2020-12-03 | Regeneron Pharmaceuticals, Inc. | Use of raman spectroscopy in downstream purification |
| CN110672655A (en) * | 2019-11-06 | 2020-01-10 | 上海卫星装备研究所 | In-situ detection system and method for thermal radiation performance |
| CN116941223A (en) * | 2021-02-23 | 2023-10-24 | 菲尼克斯电气开发及制造股份有限公司 | APL field switch with dynamic power allocation |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4774191A (en) * | 1979-09-07 | 1988-09-27 | Syntex (U.S.A.) Inc. | Fluorescent conjugates bound to a support |
| US5106729A (en) * | 1989-07-24 | 1992-04-21 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Method for visualizing the base sequence of nucleic acid polymers |
| US5837552A (en) * | 1991-07-22 | 1998-11-17 | Medifor, Ltd. | Surface-enhanced analytical procedures and substrates |
| US6149868A (en) * | 1997-10-28 | 2000-11-21 | The Penn State Research Foundation | Surface enhanced raman scattering from metal nanoparticle-analyte-noble metal substrate sandwiches |
| US6242264B1 (en) * | 1996-09-04 | 2001-06-05 | The Penn State Research Foundation | Self-assembled metal colloid monolayers having size and density gradients |
| US6342349B1 (en) * | 1996-07-08 | 2002-01-29 | Burstein Technologies, Inc. | Optical disk-based assay devices and methods |
| US6417340B1 (en) * | 1996-07-29 | 2002-07-09 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6602669B2 (en) * | 2000-07-11 | 2003-08-05 | Northwestern University | Method of detection by enhancement of silver staining |
| US6608716B1 (en) * | 1999-05-17 | 2003-08-19 | New Mexico State University Technology Transfer Corporation | Optical enhancement with nanoparticles and microcavities |
| US6770488B1 (en) * | 1999-03-19 | 2004-08-03 | The University Of Wyoming | Practical method and apparatus for analyte detection with colloidal particles |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5998135A (en) * | 1989-02-24 | 1999-12-07 | Enzo Diagnostics, Inc. | Energy transfer hybridization assay using intercalators and lanthanide metals |
| US5227487A (en) * | 1990-04-16 | 1993-07-13 | Molecular Probes, Inc. | Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes |
| WO1995008642A1 (en) * | 1993-09-23 | 1995-03-30 | Zeneca Limited | Nucleic acid detection with energy transfer |
| AT403746B (en) | 1994-04-12 | 1998-05-25 | Avl Verbrennungskraft Messtech | OPTOCHEMICAL SENSOR AND METHOD FOR THE PRODUCTION THEREOF |
| AT403961B (en) | 1995-03-17 | 1998-07-27 | Avl Verbrennungskraft Messtech | OPTOCHEMICAL MEASURING SYSTEM WITH A FLUORESCENCE SENSOR |
| US5952236A (en) * | 1995-10-26 | 1999-09-14 | Thompson; Richard B. | Enzyme-based fluorescence biosensor for chemical analysis |
| FI102922B1 (en) * | 1996-06-28 | 1999-03-15 | Valtion Teknillinen | Fluorescence based immunoassay method |
| US5864397A (en) * | 1997-09-15 | 1999-01-26 | Lockheed Martin Energy Research Corporation | Surface-enhanced raman medical probes and system for disease diagnosis and drug testing |
| US6214628B1 (en) * | 1998-01-14 | 2001-04-10 | Joseph R. Lakowicz | Method of conducting an assay of a sample containing an analyte of interest |
| WO1999044045A1 (en) * | 1998-02-27 | 1999-09-02 | Massachusetts Institute Of Technology | Single molecule detection with surface-enhanced raman scattering and applications in dna or rna sequencing |
| AU5879400A (en) * | 1999-06-29 | 2001-01-31 | Chiron Corporation | Arrays of biopolymeric agents and method for their production and use |
| AU6504900A (en) * | 1999-07-30 | 2001-02-19 | Penn State Research Foundation, The | Instruments, methods and reagents for surface plasmon resonance |
| US6485962B1 (en) * | 2000-04-05 | 2002-11-26 | Echo Technologies | Methods for signal enhancement in optical microorganism sensors |
| DE10035451C2 (en) | 2000-07-19 | 2002-12-05 | November Ag Molekulare Medizin | Method and device for identifying a polymer sequence |
| CA2438129A1 (en) | 2001-02-14 | 2002-08-22 | University Of Maryland, Baltimore | Radiative decay engineering |
-
2002
- 2002-02-11 CA CA002438129A patent/CA2438129A1/en not_active Abandoned
- 2002-02-11 US US10/073,625 patent/US20020160400A1/en not_active Abandoned
- 2002-02-11 EP EP02718938A patent/EP1360332A4/en not_active Withdrawn
- 2002-02-11 MX MXPA03007147A patent/MXPA03007147A/en not_active Application Discontinuation
- 2002-02-11 WO PCT/US2002/003901 patent/WO2002064837A1/en active Application Filing
- 2002-02-11 JP JP2002564151A patent/JP2004524528A/en active Pending
-
2004
- 2004-11-18 US US10/990,549 patent/US7776528B2/en not_active Expired - Fee Related
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4774191A (en) * | 1979-09-07 | 1988-09-27 | Syntex (U.S.A.) Inc. | Fluorescent conjugates bound to a support |
| US5106729A (en) * | 1989-07-24 | 1992-04-21 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Method for visualizing the base sequence of nucleic acid polymers |
| US5837552A (en) * | 1991-07-22 | 1998-11-17 | Medifor, Ltd. | Surface-enhanced analytical procedures and substrates |
| US6342349B1 (en) * | 1996-07-08 | 2002-01-29 | Burstein Technologies, Inc. | Optical disk-based assay devices and methods |
| US6417340B1 (en) * | 1996-07-29 | 2002-07-09 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6242264B1 (en) * | 1996-09-04 | 2001-06-05 | The Penn State Research Foundation | Self-assembled metal colloid monolayers having size and density gradients |
| US6149868A (en) * | 1997-10-28 | 2000-11-21 | The Penn State Research Foundation | Surface enhanced raman scattering from metal nanoparticle-analyte-noble metal substrate sandwiches |
| US6770488B1 (en) * | 1999-03-19 | 2004-08-03 | The University Of Wyoming | Practical method and apparatus for analyte detection with colloidal particles |
| US6608716B1 (en) * | 1999-05-17 | 2003-08-19 | New Mexico State University Technology Transfer Corporation | Optical enhancement with nanoparticles and microcavities |
| US6602669B2 (en) * | 2000-07-11 | 2003-08-05 | Northwestern University | Method of detection by enhancement of silver staining |
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050202464A1 (en) * | 2001-02-14 | 2005-09-15 | University Of Maryland, Baltimore | Radiative decay engineering |
| US7776528B2 (en) | 2001-02-14 | 2010-08-17 | University Of Maryland, Baltimore | Radiative decay engineering |
| US20030228682A1 (en) * | 2002-04-30 | 2003-12-11 | University Of Maryland, Baltimore | Fluorescence sensing |
| US20040087006A1 (en) * | 2002-10-28 | 2004-05-06 | Leica Microsystems Heidelberg Gmbh | Sample carrier for a confocal microscope and method for fabricating a sample carrier |
| US7583436B2 (en) * | 2002-10-28 | 2009-09-01 | Leica Microsystems Cms Gmbh | Sampler carrier for a confocal microscope and method for fabricating a sample carrier |
| US20060147927A1 (en) * | 2002-11-26 | 2006-07-06 | Geddes Chris D | High-sensitivity assays for pathogen detection using metal enhanced fluorescence |
| US9170197B2 (en) | 2002-11-26 | 2015-10-27 | University Of Maryland, Baltimore County | High-sensitivity assays for pathogen detection using metal-enhanced fluorescence |
| US8114598B2 (en) | 2002-11-26 | 2012-02-14 | University Of Maryland, Baltimore County | High-sensitivity assays for pathogen detection using metal enhanced fluorescence |
| US20040235185A1 (en) * | 2003-02-04 | 2004-11-25 | Carina Horn | Fluorimetric determination of analytes by amine-N-oxides as redox indicators |
| US7723121B2 (en) * | 2003-02-04 | 2010-05-25 | Carina Horn | Fluorimetric determination of analytes by amine-N-oxides as redox indicators |
| US8431410B2 (en) | 2003-02-04 | 2013-04-30 | Roche Diagnostics Operations, Inc. | Amine-N-oxide redox indicators for fluorimetric determination of analytes |
| US20100221699A1 (en) * | 2003-02-04 | 2010-09-02 | Carina Horn | Amine-n-oxide redox indicators for fluorimetric determination of analytes |
| DE10314579A1 (en) * | 2003-03-31 | 2004-10-14 | Carl Zeiss Jena Gmbh | Apparatus for sequence analysis of nucleic acids has channels with fixed metal particles, where the sample is moved past them with an excitation beam for fluorescence to be passed through spectral analysis for evaluation |
| US20080286880A1 (en) * | 2004-07-07 | 2008-11-20 | The Penn State Research Foundation | Methods and Systems for Nanoparticle Enhancement of Signals |
| US7511285B2 (en) | 2004-07-16 | 2009-03-31 | The Charles Stark Draper Laboratory, Inc. | Methods and apparatus for biomolecule identification |
| US20060011862A1 (en) * | 2004-07-16 | 2006-01-19 | The Charles Stark Draper Laboratory, Inc. | Methods and apparatus for biomolecule identification |
| US8563328B2 (en) * | 2004-07-26 | 2013-10-22 | University Of Louisville Research Foundation, Inc. | Fiber-optic biosensor and biosensing methods |
| US20060286680A1 (en) * | 2004-07-26 | 2006-12-21 | University Of Louisville Research Foundation | Fiber-optic biosensor and biosensing methods |
| US20060024771A1 (en) * | 2004-07-26 | 2006-02-02 | University Of Louisville Research Foundation | Enhancement of sensitivity of fluorophore mediated biosensing and bioimaging |
| US7871573B2 (en) * | 2004-07-26 | 2011-01-18 | University Of Louisville Research Foundation, Inc. | Enhancement of sensitivity of fluorophore mediated biosensing and bioimaging |
| WO2006034045A1 (en) * | 2004-09-16 | 2006-03-30 | Ut-Battelle, Llc | Transparent solid-state structure for diagnostics of fluorescently labeled biomolecules |
| WO2006088976A3 (en) * | 2005-02-16 | 2009-08-20 | Univ Louisville Res Found | Fiber-optic biosensor and biosensing methods |
| US8383415B2 (en) | 2005-10-13 | 2013-02-26 | Dso National Laboratories | Hydrogel composition to enhance fluorescence |
| US20090130773A1 (en) * | 2005-10-13 | 2009-05-21 | Teck Choon Ayi | Method of Enhancing a Fluorescent Signal |
| US8105819B2 (en) * | 2006-01-17 | 2012-01-31 | Moore Wayne E | Plasmon fluorescence augmentation for chemical and biological testing apparatus |
| US20100144557A1 (en) * | 2006-01-17 | 2010-06-10 | Moore Wayne E | Plasmon fluorescence augmentation for chemical and biological testing apparatus |
| US20090069743A1 (en) * | 2007-09-11 | 2009-03-12 | Baxter International Inc. | Infusion therapy sensor system |
| US20140038176A1 (en) * | 2010-11-11 | 2014-02-06 | Sony Corporation | Method of detecting nucleic acids, method of optically observing sample and fluorescent substance |
| US9459213B2 (en) * | 2010-11-11 | 2016-10-04 | Sony Corporation | Method of detecting nucleic acids, method of optically observing sample and fluorescent substance |
| US10982255B2 (en) * | 2012-05-10 | 2021-04-20 | Sony Corporation | Microchip for nucleic acid analysis |
Also Published As
| Publication number | Publication date |
|---|---|
| US7776528B2 (en) | 2010-08-17 |
| CA2438129A1 (en) | 2002-08-22 |
| JP2004524528A (en) | 2004-08-12 |
| EP1360332A1 (en) | 2003-11-12 |
| US20050202464A1 (en) | 2005-09-15 |
| WO2002064837A1 (en) | 2002-08-22 |
| MXPA03007147A (en) | 2003-11-18 |
| EP1360332A4 (en) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7776528B2 (en) | Radiative decay engineering | |
| JP3605607B2 (en) | Detection method by enhanced silver staining | |
| Lakowicz et al. | Advances in surface-enhanced fluorescence | |
| CA1285330C (en) | Analyte detection by means of energy transfer | |
| Malicka et al. | DNA hybridization assays using metal-enhanced fluorescence | |
| US8980179B2 (en) | Angular-dependent metal-enhanced fluorescence | |
| AU755913B2 (en) | Nucleic acid biosensor diagnostics | |
| US8759110B2 (en) | Metal enhanced fluorescence-based sensing methods | |
| US20030228682A1 (en) | Fluorescence sensing | |
| Malicka et al. | Fluorescence spectral properties of cyanine dye-labeled DNA oligomers on surfaces coated with silver particles | |
| US20040023293A1 (en) | Biochips for characterizing biological processes | |
| Lakowicz et al. | Effects of metallic silver particles on resonance energy transfer between fluorophores bound to DNA | |
| EP1521843B1 (en) | Method for chemiluminescent detection | |
| Culha et al. | Surface-enhanced Raman scattering for cancer diagnostics: detection of the BCL2 gene | |
| Malicka et al. | Fluorescence spectral properties of cyanine dye labeled DNA near metallic silver particles | |
| DE10141691A1 (en) | Displacement assay for the detection of ligate-ligand association events | |
| EP3356547B1 (en) | Method for detecting molecular interactions using an immobilized nucleic acid | |
| AU2002250047A1 (en) | Radiative decay engineering | |
| Li et al. | Ultra-sensitive DNA assay based on single-molecule detection coupled with fluorescent quantum dot-labeling and its application to determination of messenger RNA | |
| US20090092966A1 (en) | Colloidal metal aggregates and methods of use | |
| WO2004046100A2 (en) | Release of the self-quenching of fluorescence near silver metallic surfaces | |
| DE10041809A1 (en) | Arrays of immobilized biomolecules, their manufacture and use | |
| Aslan et al. | Metal‐Enhanced Fluorescence: Application to High‐Throughput Screening and Drug Discovery | |
| Lakowicz | Chris D. Geddes* 1, 2, Kadir Aslan¹, Ignacy Gryczynski², Joanna Malicka² | |
| CA2294603A1 (en) | Nucleic acid biosensor diagnostics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: UNIVERSITY OF MARYLAND, BALTIMORE, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LAKOWICZ, JOSEPH;REEL/FRAME:012837/0662 Effective date: 20020319 |
|
| AS | Assignment |
Owner name: UNIVERSITY OF MARYLAND, BALTIMORE, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LAKOWICZ, JOSEPH R.;REEL/FRAME:014531/0163 Effective date: 20030522 |
|
| AS | Assignment |
Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF Free format text: EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF MARYLAND, BALTIMORE;REEL/FRAME:020981/0993 Effective date: 20040325 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |